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Ataxia
Ataxia derives from the Greek word ataxis, and means lack of order. Hippocrates 
and Galenus used it as a medical term for everything involving irregular 
movements, such as an irregular pulse.1 Nowadays, the term ataxia is used to 
describe incoordination of voluntary movements. Cerebellar ataxia needs to be 
distinguished from sensory ataxia. The latter is due to loss of proprioception, 
generally caused by large fiber peripheral neuropathies and conditions causing 
dysfunction of the dorsal columns of the spinal cord. Typically, sensory ataxia 
worsens upon eye closure. Cerebellar ataxia is the result of dysfunction of the 
cerebellum and its connections. In contrast to sensory ataxia, cerebellar ataxia 
does not worsen markedly upon eye closure, and is often accompanied by other 
cerebellar signs, such as eye movement abnormalities (jerky pursuit, gaze-evoked 
nystagmus, dysmetric saccades) and dysarthria. Sensory and cerebellar ataxia 
can sometimes coexist, for example in some genetic ataxias.2, 3
 Cerebellar ataxia can have a great impact on quality of life, mainly due to 
impaired dexterity, balance disturbances, and consequently falls. Furthermore, 
cerebellar ataxia is a challenging symptom for clinicians in daily practice, because 
of the extensive differential diagnosis, the lack of treatment options, the long list 
of potential concomitant symptoms, and the consequences of ataxia for daily life 
of patients.
 This Introduction means to give a more general, concise and practical 
overview of cerebellar ataxias, mainly focussing on the clinical reasoning, but 
also including comments on the management of cerebellar ataxia. The focus of 
this chapter and thesis will be on adult-onset ataxias, i.e. not on congenital or 
childhood-onset ataxias (although some diseases that typically start in adulthood 
can start earlier in life). 
Differential diagnosis and diagnostic work up of cerebellar ataxia
The causes of cerebellar ataxia are numerous. Even some of the relatively 
frequent causes are quite rare, which makes the diagnostic work-up of patients 
with ataxia rather complicated. For a focused differential diagnosis and targeted 
work-up, carefully history taking and looking for relevant clues during the physical 
examination are crucial.
 
Relevant information from the history
Continuous or episodic
When ataxia appears to be episodic, the differential diagnosis is very limited, and 
mainly includes migraine and the genetic episodic ataxias. Basilar-type migraine, 
familial hemiplegic migraine (FHM1) and sporadic hemiplegic migraine can cause 
episodic ataxia, which is most often accompanied by vertigo, dysarthria and 
visual disturbances, typically followed by a pounding occipital headache and 
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nausea, which completely resolve after some hours. Two-thirds of the patients 
with FMH1 have permanent cerebellar involvement, including gaze-evoked 
nystagmus, ataxia, and atrophy of the vermis. Some families have severe attacks 
with coma or prolonged hemiplegia, with full recovery.4, 5 
 There are seven genotypes of dominantly inherited episodic ataxias (EAs), 
of which EA1 and EA2 are most common. Onset is usually in late childhood or 
adolescence. Mutations can be de novo, leading to a negative family history. 
Depending on the mutation, patients experience episodes of ataxia lasting 
minutes to hours, occasionally days. There may be other accompanying features, 
such as vertigo or tinnitus, which sometimes predominate. Interictal findings are 
indicative, for example myokymia points to EA1, and nystagmus to EA2. In EA2, 
there may be a slowly progressive cerebellar syndrome that evolves over the years.6
Speed of onset and progression rate
Acute onset of cerebellar ataxia obviously suggests a stroke of the cerebellum 
or brainstem. Ataxia developing over hours may be due to alcohol intoxication 
or Wernicke’s encephalopathy. Wernicke’s encephalopathy, caused by vitamin 
B1 deficiency, is characterized by encephalopathy, oculomotor dysfunction and 
gait ataxia as the classic triad, and requires immediate vitamin B1 replacement. 
Symptoms that develop over days may be the result of Miller Fisher syndrome 
or postinfectious cerebellitis (which is rare in adults). Progression in weeks 
to months is seen in structural lesions of the cerebellum or brainstem, ataxia 
due to drugs, paraneoplastic cerebellar degeneration, steroid-responsive 
encephalopathy with antithyroid antibodies (SREAT, formerly known as 
Hashimoto’s encephalopathy), Creutzfeldt-Jakob disease, and antiglutamic acid 
decarboxylase (anti-GAD)-associated cerebellar ataxia. A gradual onset and 
progression over years often points to a degenerative cause. There are obvious 
exceptions to these lists, but the message is that onset speed and progression 
rate clearly makes some conditions far more likely than others.
 
Onset at age
Particularly for the genetic ataxias, age at onset seems to be a less useful 
indicator. For example, some of the recessive ataxias - which were previously 
assumed to begin in early life - can start really late.7 Still, an onset below 40 
years of age has an increased likelihood of being genetic in origin, in comparison 
with an onset after that age. Multiple system atrophy (MSA) does not need to be 
considered before 30 years of age8, and the fragile X tremor/ataxia syndrome 
(FXTAS) generally starts after 50 years of age.9
Family history
A genetic cause is of course evident if there is a family history of cerebellar 
ataxia. The mode of inheritance, suggested by the pedigree, determines which 
genetic mutations should be looked for. A negative history does not exclude a 
genetic cause. It is important not only to ask for ataxia in other family members, 
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but also for other movement disorders (e.g. parkinsonism is relatively common in 
SCA2, and chorea can be part of the SCA17 phenotype), for mental retardation 
and premature ovarian failure (for FXTAS), and for deafness and diabetes mellitus 
(for mitochondrial disorders). 
General medical status
Changes in body weight and diarrhea can point towards a thyroid problem or to 
celiac disease. Patients with a history of malignancy may have paraneoplastic 
cerebellar degeneration. HIV patients may develop a cerebellar ataxia due 
to various reasons (opportunistic infections, primary CNS lymphoma, etc.). 
Autonomic problems, such as urinary incontinence or orthostatic hypotension, 
suggest MSA. If the patient has a history of longstanding alcohol abuse, the 
likely diagnosis is alcoholic cerebellar degeneration, or – if the ataxia developed 
over hours - Wernicke’s encephalopathy due to B1 deficiency (secondary to 
malnutrition).
Exogenous substances 
Longstanding alcohol abuse is the most common exogenous substance 
that causes chronic ataxia. Although alcohol is the most frequent cause of 
sporadic ataxias in middle-aged men, a search for other causes still needs to 
be considered if the alcohol abuse has not been too excessive, or if there is 
progression after stopping alcohol intake. Other exogenous substances that can 
cause ataxia include cannabis, NMDA receptor antagonists, and heavy metals 
such as mercury, organo-lead components and methylmercury.10
 Various prescription drugs, such as antiepileptic drugs, amiodarone, 
benzodiazepines and lithium can cause ataxia, which is reversible in the majority. 
Chemotherapy, especially 5-fluorouracil, cytarabine and methotrexate, is 
associated with both reversible and permanent cerebellar ataxia, and also can 
lead to permanent sensory ataxia, due to peripheral neuropathy.11, 12
Relevant clues from the physical examination 
The neurological examination should firstly confirm that there is indeed a 
cerebellar ataxia. Relevant other elements of the neurological examination 
include peripheral neuropathy, spasticity (the spastic ataxias have a limited 
number of underlying causes), or any other movement disorder. It is worthwhile 
to invest in the examination of eye movements. There could be some more 
‘standard’ cerebellar eye movement abnormalities, such as jerky pursuit, gaze-
evoked nystagmus, and dysmetric saccades. However, some other eye signs are 
very indicative. For example, a severe difficulty to generate saccades (sometimes 
referred to as oculomotor apraxia) has a limited differential diagnosis (namely 
that of ataxia telangiectasia, or of ataxia with oculomotor apraxia type 2).  
A gaze limitation in the vertical plane might suggest Niemann-Pick type C. Some 
dominant ataxias (e.g. SCA1) and mitochondrial disorders are accompanied by a 
more extensive ophthalmoplegia. 
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 The non-neurological signs to check are skeletal abnormalities like scoliosis 
(e.g. Friedreich ataxia), telangiectasias (ataxia telangiectasia) and orthostatic 
hypotension (MSA).
Investigations
Tables 1 and 2 show possible causes of non-genetic and genetic ataxias, 
respectively, including associated symptoms, abnormalities on MRI imaging, and 
suggestions for further investigation. Not included in the table are ataxias due to 
traumatic brain injury, hypoxic encephalopathy, radiation, high altitude cerebral 
edema, and heat stroke, which are evident from the history.
 The investigation of patients with cerebellar ataxia should always begin with 
an MRI brain scan, or a CT brain scan in acute onset ataxias. The only exception 
might be the patient in whom there is a known genetic ataxia with a compatible 
clinical presentation. If the MRI shows no structural lesion, there may be 
hallmarks of specific ataxia causes. (Table 1 and 2) 
For the further phenotyping, electrophysiological investigations need to be 
considered. It is particularly useful to ascertain whether or not a peripheral 
neuropathy is present. Also, an ophthalmology referral is sometimes required 
to exclude or confirm abnormalities of the optic nerves (atrophy, edema), retinal 
pigmentary changes, macular dystrophy, and Kayser-Fleischer rings. 
TABLE 1 Acquired and (non-genetic) degenerative causes of cerebellar ataxia 13, 14
CAUSE CLUES SUGGESTIONS FOR INVESTIGATION
Structural lesions
Stroke, MS, space occupying 
lesions, Chiari malformation
Focal neurological signs, headache Investigations depend on findings on 
CT or MRI brain scan
Toxic
Alcohol Medical history, concomitant 
neuropathy
Liver enzymes, MCV, vitamin B1
MRI: anterior vermis atrophy
Drugs, heavy metals Medical history Blood level drug, stop use or 
exposure
Inflammatory
Paraneoplastic cerebellar 
degeneration
Rapid progression, history of 
malignancy
Anti-neuronal antibodies, tumor screen
MRI: cerebellar atrophy (later stages)
Anti-GAD ataxia Subacute, type 1 diabetes mellitus Anti-GAD antibodies
MRI: cerebellar atrophy (later stages)
Steroid-responsive encephalopathy 
with antithyroid antibodies
Subacute, seizures, myoclonus, 
rapid response to steroids
Anti-thyroperoxidase antibodies
Gluten ataxia Gastro-intestinal symptoms Anti-tissue transglutaminase and anti-
endomysium antibodies, bowel biopsy
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CAUSE CLUES SUGGESTIONS FOR INVESTIGATION
(Para)infectious
Epstein-Barr virus Subacute, preceding infection Serologic testing, CSF
Miller Fisher syndrome Subacute, ophthalmoplegia, areflexia Anti-GQ1b antibodies, EMG
HIV-related ataxia History of HIV infection
Opportunistic infections such as 
toxoplasmosis, PML
MRI, CSF, search for opportunistic 
infections
Whipple’s disease Fever, weight loss, diarrhea, 
abdominal pain, arthritis
PCR finding of Tropheryma whipplei in 
duodenal biopsy 
Tabetic neurosyphilis History of syphilis, sensory ataxia TPHA, CSF
Metabolic
Vitamin B1 deficiency
(Wernicke’s encephalopathy)
Confusion, nystagmus, 
ophthalmoplegia
Vitamin B1 level
MRI: bilateral increased T2 signal 
in the thalamus, hypothalamus, 
mammillary bodies, periaqueductal 
region, fourth ventricle floor, and 
midline cerebellum
Vitamin E deficiency Diarrhea Vitamin E level, celiac screen, serum 
amylase
Hypothyroidism Fatigue, weight gain, constipation Thyroid stimulating hormone, free T4
Hypoparathyroidism Cataract, extrapyramidal symptoms Parathyroid hormone, calcium, 
phosphate
CT: cerebellar and basal ganglia 
calcifications
Other
Superficial siderosis Sensorineural deafness, pyramidal 
signs
Audiogram, xanthochromic CSF
MRI: linear hypointensity in the 
posterior fossa on T2-weighted 
gradient-recalled echo
Degenerative
Multiple System Atrophy Autonomic failure, parkinsonism Autonomic testing
MRI: hot cross bun sign 
(pontocerebellar fiber degeneration) 
and putaminal rim (high signal line 
extending laterally from slightly 
darkened putamen)
Idiopathic late onset cerebellar 
ataxia/sporadic adult-onset ataxia
Relatively pure ataxia, slow 
progression
MRI: cerebellar atrophy
Sporadic Creutzfeldt-Jakob disease Rapid progression, cognitive 
disturbances, myoclonus, pyramidal 
tract signs
14-3-3 and tau protein CSF, EEG
MRI: Increased signal in basal ganglia 
and cortex on FLAIR and diffusion-
weighted MRI
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TABLE 2 Some important genetic causes of cerebellar ataxia 7, 13, 14
CAUSE CLUES SUGGESTIONS FOR INVESTIGATION
Dominant
Spinocerebellar ataxias Family history, slow progression, 
non-ataxia symptoms, some 
genotype-specific features
Mutation analysis of SCA genes, 
repeat expansion SCAs first
MRI: cerebellar atrophy
Dentato-rubro-pallidoluysian 
atrophy
Family history, chorea, dementia, 
myoclonus, Japanese descent
Mutation analysis of ATN1 gene
Alexander disease (Pseudo)bulbar signs, spasticity Mutation analysis of GFAP gene
MRI: tadpole sign (atrophy of the 
medulla and cervical cord with a 
preserved pontine volume
Gerstmann-Straussler syndrome Family history, pyramidal signs, 
adult-onset dementia
Mutation analysis of PRNP gene
Recessive
Autosomal recessive cerebellar 
ataxias (in general)
Family history, often neuropathy, 
systemic features
Mutation analysis of recessive genes, 
lysosomal enzymes, metabolic 
investigation, α-fetoprotein
Wilson’s disease Kayser-Fleischer rings, dystonia, 
parkinsonism, renal tubular 
acidosis, cardiomyopathy
Ceruloplasmin, serum and urine 
copper, liver enzymes, renal function
Mutation analyses of ATP7B gene
MRI: hyperintense T2 signal changes 
in basal ganglia
Friedreich ataxia Age at onset 5-25 years, late 
onset possible. Mixed cerebellar/
sensory ataxia, areflexia, pyramidal 
weakness, scoliosis 
Mutation analysis of FRDA gene
Ataxia telangiectasia Age of onset 2-3 years. 
Oculomotor apraxia, conjunctival 
telangiectasias, extrapyramidal 
signs, predisposition to cancer. 
Milder variants exist
α-fetoprotein 
Mutation analysis of ATM gene
Ataxia with oculomotor apraxia 
types 1 
Like ataxia telangiectasia, 
sensorimotor neuropathy, chorea, 
mental retardation
Albumin, cholesterol
Mutation analysis of APTX
Ataxia with oculomotor apraxia 
type 2
Ataxia with oculomotor apraxia type 1, 
some features in lesser degree, 
oculomotor apraxia
Serum α-fetoprotein
Mutation analysis of SETX
Autosomal recessive cerebellar 
ataxia (ARCA) with psychomotor 
retardation
Psychomotor retardation in early life, 
late-onset ataxia
Mutation analysis of SYT14
ARCA1 Relatively pure cerebellar syndrome Mutation analysis of SYNE1
ARCA3 Downbeat nystagmus, lower motor 
neuron involvement
Mutation analysis of ANO10
Autosomal recessive spastic ataxia 
of Charlevoix-Saguenay
Spasticity, severe neuropathy, onset 
below age 10 years
Mutation analysis of SACS
SANDO/MIRAS Ophthalmoplegia, myoclonus, 
dystonia, neuropathy
Mutation analysis of POLG1
MRI: cerebellar white matter high-
signal changes
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CAUSE CLUES SUGGESTIONS FOR INVESTIGATION
Late-onset Tay-Sachs disease Proximal muscle weakness and 
atrophy, behavioral problems, 
areflexia
Enzyme assay hexosaminidase A
Mutation analysis of HEXA
Cerebrotendinous xanthomatosis Tendon xanthomas, diarrhea, 
pyramidal or extrapyramidal signs, 
seizures, dementia, cataract
Cholestanol 
Bile alcohols in urine
Mutation analysis of CYP27
MRI: cerebellar white matter high-
signal changes
Refsum’s disease Demyelinating polyneuropathy, 
sensorineural deafness, retinitis 
pigmentosa, anosmia
Phytanic acid
Mutation analysis of PHYH and PEX7
Other
Fragile X-associated tremor/ataxia 
syndrome
Family history (learning disability 
premature ovarian failure), mostly 
men, action tremor, behavioral 
changes, autonomic dysfunction
Mutation analysis of FMR1 gene
MRI: hyperintense signal changes 
lateral to dentate nucleus extending 
into middle cerebral peduncles, 
often generalized atrophy
Mitochondrial disorders Family history, diabetes, deafness, 
multisystem involvement
Mutation analysis of mitochondrial 
DNA and POLG1, muscle biopsy 
Heredo-degenerative ataxias
Heredo-degenerative cerebellar ataxias form an interesting group, due to their 
clinical and genetic heterogeneity and in light of the on-going discovering of new 
genes. The worldwide incidence of these ataxias is estimated to be 5.2-18.5 per 
100.000 inhabitants.15-20
 Degenerative ataxias are characterized by an impairment of gait, balance, 
limb coordination, speech and eye movements. A plethora of other symptoms 
and signs may arise, and these are sometimes very specific for one of 
these disorders.21 Symptoms are progressive and eventually lead to serious 
deterioration of mobility, independence, and quality of life.22, 23 A prior study found 
that falls occur very frequently in these patients, and that these falls often lead 
to injuries and a fear of falling.24
 Many degenerative ataxias have a genetic cause. Based on the mode of 
inheritance or on the identified gene defect, hereditary ataxias can be categorized 
into autosomal dominant, autosomal recessive, X-linked, and maternally inherited 
disorders. This thesis focuses mainly on autosomal dominant cerebellar ataxias 
(ADCAs), which are currently referred to as spinocerebellar ataxias (SCAs). The 
prevalence in The Netherlands has been estimated at about 3 per 100,000, but 
is probably higher.16
 An important non-genetic, degenerative ataxia to consider is multiple system 
atrophy (MSA). If no exact cause can be established, the terms Idiopathic Late 
Onset Ataxia (ILOCA) or Sporadic Adult-Onset Ataxia of unknown etiology (SAOA) 
are used.25 These are usually relatively slow progressive and rather pure ataxias. 
If not, one should reconsider diagnosis.
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Treatment and management of cerebellar ataxia
For only a small number of cerebellar disorders there is a specific treatment. 
Some specific interventions include stopping the offending substance in 
toxic ataxia; starting vitamin supplements in vitamin deficiencies; specific 
dietary recommendations in celiac disease and Refsum’s disease, starting 
corticosteroids in patients with SREAT or ataxia associated with anti-GAD 
antibodies, treating the underlying tumor and starting immunomodulatory 
treatment in paraneoplastic cerebellar degeneration, and giving bile acid 
replacement in cerebrotendinous xanthomatosis. With regard to symptomatic, 
anti-ataxia drugs such as amantadine or riluzole, the number of well conducted 
studies is disappointingly low and therefore evidence to support their use in 
practice is lacking.26 Drugs for the potential other disease manifestations are 
available, for example, to partially alleviate spasticity, nystagmus, parkinsonism, 
orthostatic hypotension, or urinary urgency. 
 However, for most patients there is no specific treatment and the aim 
is then to provide symptomatic relief and supportive care and to prevent 
further complications. Other specialist doctors that are often needed include 
rehabilitation specialists, clinical geneticists, and urologists. 
Allied health care
Patients are often referred to allied health care interventions, which are 
considered as the cornerstone in further management.27, 28 Physical therapy, 
speech therapy, and occupational therapy are expected to prevent secondary 
complications and minimize dependency in daily life in patients with ataxia. 
However, despite the many referrals, there is not much known about when and 
where to refer patients, and which training program to use. There is not much 
scientific evidence for the effectiveness of interventions used in allied health 
care, leading to a lack of evidence-based treatment guidelines and a marked 
heterogeneity of treatments that patients with ataxia receive.29
FALLS, PHYSIOTHERAPY AND TRAINING IN PATIENTS WITH CEREBELLAR DEGENERATION 19
REFERENCES 
1.  Anthoney TR, editor. Neuroanatomy and the Neurologic Exam: A Thesaurus of Synonyms, 
Similar-Sounding Non-Synonyms, and Terms of Variable Meaning: CRC Press, 1993.
2.  Klockgether T. Parkinsonism & related disorders. Ataxias. Parkinsonism Relat Disord 
2007;13 Suppl 3:S391-394.
3.  Schols L, Bauer P, Schmidt T, Schulte T, Riess O. Autosomal dominant cerebellar ataxias: 
clinical features, genetics, and pathogenesis. Lancet Neurol 2004;3:291-304.
4.  Headache Classification Subcommittee of the International Headache S. The International 
Classification of Headache Disorders: 2nd edition. Cephalalgia 2004;24 Suppl 1:9-160.
5.  Russell MB, Ducros A. Sporadic and familial hemiplegic migraine: pathophysiological 
mechanisms, clinical characteristics, diagnosis, and management. Lancet Neurol 
2011;10:457-470.
6.  Jen JC, Graves TD, Hess EJ, et al. Primary episodic ataxias: diagnosis, pathogenesis and 
treatment. Brain 2007;130:2484-2493.
7.  Vermeer S, van de Warrenburg BP, Willemsen MA, et al. Autosomal recessive cerebellar 
ataxias: the current state of affairs. J Med Genet 2011;48:651-659.
8.  Peeraully T. Multiple system atrophy. Seminars in neurology 2014;34:174-181.
9.  Hagerman PJ, Hagerman RJ. Fragile X-associated tremor/ataxia syndrome. Ann N Y Acad 
Sci 2015;1338:58-70.
10.  Diez S. Human health effects of methylmercury exposure. Reviews of environmental 
contamination and toxicology 2009;198:111-132.
11.  Schiff D, Wen PY, van den Bent MJ. Neurological adverse effects caused by cytotoxic and 
targeted therapies. Nat Rev Clin Oncol 2009;6:596-603.
12.  Sioka C, Kyritsis AP. Central and peripheral nervous system toxicity of common 
chemotherapeutic agents. Cancer Chemother Pharmacol 2009;63:761-767.
13.  van Gaalen J, van de Warrenburg BP. A practical approach to late-onset cerebellar ataxia: 
putting the disorder with lack of order into order. Pract Neurol 2012;12:14-24.
14.  van de Warrenburg BP, van Gaalen J, Boesch S, et al. EFNS/ENS Consensus on the 
diagnosis and management of chronic ataxias in adulthood. Eur J Neurol 2014;21:552-562.
15.  Berciano J, Infante J, Mateo I, Combarros O. [Hereditary ataxias and paraplegias: a 
clinicogenetic review]. Neurologia 2002;17:40-51.
16.  van de Warrenburg BP, Sinke RJ, Verschuuren-Bemelmans CC, et al. Spinocerebellar 
ataxias in the Netherlands: prevalence and age at onset variance analysis. Neurology 
2002;58:702-708.
17.  Koht J, Tallaksen CM. Cerebellar ataxia in the eastern and southern parts of Norway. Acta 
neurologica Scandinavica Supplementum 2007;187:76-79.
18.  Infante J, Combarros O, Volpini V, Corral J, Llorca J, Berciano J. Autosomal dominant 
cerebellar ataxias in Spain: molecular and clinical correlations, prevalence estimation 
and survival analysis. Acta Neurol Scand 2005;111:391-399.
19.  Joo BE, Lee CN, Park KW. Prevalence rate and functional status of cerebellar ataxia in 
Korea. Cerebellum 2012;11:733-738.
20.  Tsuji S, Onodera O, Goto J, Nishizawa M, Study Group on Ataxic D. Sporadic ataxias in 
Japan--a population-based epidemiological study. Cerebellum 2008;7:189-197.
20 CHAPTER 1 INTRODUCTION 
21.  Verbeek DS, van de Warrenburg BP. Genetics of the dominant ataxias. Seminars in 
neurology 2011;31:461-469.
22.  Brusse E, Brusse-Keizer MG, Duivenvoorden HJ, van Swieten JC. Fatigue in 
spinocerebellar ataxia: patient self-assessment of an early and disabling symptom. 
Neurology 2011;76:953-959.
23.  Schmitz-Hubsch T, Coudert M, Giunti P, et al. Self-rated health status in spinocerebellar 
ataxia--results from a European multicenter study. Mov Disord 2010;25:587-595.
24.  van de Warrenburg BP, Steijns JA, Munneke M, Kremer BP, Bloem BR. Falls in 
degenerative cerebellar ataxias. Mov Disord 2005;20:497-500.
25.  Klockgether T. Sporadic adult-onset ataxia of unknown etiology. Handb Clin Neurol 
2012;103:253-262.
26.  Trujillo-Martin MM, Serrano-Aguilar P, Monton-Alvarez F, Carrillo-Fumero R. Effectiveness 
and safety of treatments for degenerative ataxias: a systematic review. Mov Disord 
2009;24:1111-1124.
27.  Marsden J, Harris C. Cerebellar ataxia: pathophysiology and rehabilitation. Clin Rehabil 
2011;25:195-216.
28.  Fonteyn EM, Keus SH, Verstappen CC, van de Warrenburg BP. Physiotherapy in 
degenerative cerebellar ataxias: utilisation, patient satisfaction, and professional 
expertise. Cerebellum 2013;12:841-847.
29.  Fonteyn EM, Keus SH, Verstappen CC, Schols L, de Groot IJ, van de Warrenburg BP. The 
effectiveness of allied health care in patients with ataxia: a systematic review. J Neurol 
2014;261:251-258.
21FALLS, PHYSIOTHERAPY AND TRAINING IN PATIENTS WITH CEREBELLAR DEGENERATION
Chapter 2
FALLS, PHYSIOTHERAPY AND TRAINING IN PATIENTS WITH CEREBELLAR DEGENERATION 23
Falls are one of the major consequences of balance and gait disorders. At the 
time of this thesis, not much was known about the prevalence, impact and 
mechanisms underlying these falls in patients with cerebellar degeneration. This 
lack of knowledge contrasts with the large number of studies that have been 
conducted for other neurological conditions, such as patients with Parkinson’s 
disease or patients with a stroke.1-4 The first part of this thesis (chapters 3.1 and 
3.2) describes the results of a European retrospective study and a prospective 
study among patients with degenerative ataxia, which aimed to obtain further 
insight into the incidence, characteristics and consequences of falls and near-
falls in patients with degenerative cerebellar ataxia. Such details are required to 
design better tailored fall prevention programs. 
 The second part of the thesis (chapter 4.1 - 4.3) focuses on allied 
health care, and especially on training by physiotherapists in patients with 
cerebellar ataxia. Many patients with degenerative cerebellar ataxia are 
referred to physiotherapy, probably stimulated by the fact that symptomatic 
pharmacotherapy and curative therapies are currently unavailable. While allied 
health care therapies are responsible for a significant portion of the annual 
health care expenses in this group of patients, actual data on the quantity and 
quality of such interventions were lacking. Chapter 4.1 provides a systematic 
review of the effectiveness of allied health care in patients with cerebellar 
ataxia. Chapter 4.2 describes the results of a national questionnaire study, 
providing more insight into the referral patterns, utilisation, patient satisfaction 
and professional expertise concerning physiotherapy in patients with cerebellar 
degeneration.
 From the systematic review described in chapter 4.1, it became clear that 
an intensive, targeted, and high-frequency training, followed by chronic, less 
intensive training at home or at a physiotherapist practice, might be the best 
training strategy in patients with cerebellar degeneration. We, therefor, chose 
to perform a pilot study on the effect of a gait adaptability training program in 
patients with cerebellar ataxia. Previous studies showed positive effects of such 
a training on gait and balance parameters in patients suffering from stroke, and 
also demonstrated an improvement of obstacle avoidance in healthy elderly.5-7 
The results of this study are described in chapter 4.3.
  Finally, the results presented in this thesis are summarized and discussed in 
chapter 5. A summary written in Dutch is included in chapter 6.
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Abstract
The objectives were to investigate the frequency, details and consequences 
of falls in patients with autosomal dominant spinocerebellar ataxias (SCAs), 
and to derive specific disease-related risk factors that are associated 
with an increased fall frequency. 228 patients with SCA1, SCA2, SCA3 or 
SCA6, recruited from the EuroSCA natural history study, completed a fall 
questionnaire that assessed the frequency, consequences, and several details 
of falls in the previous twelve months. Relevant disease characteristics were 
retrieved from the EuroSCA registry. The database of the natural history study 
provided the ataxia severity scores as well as the number and nature of non-
ataxia symptoms. 73.6 percent of patients reported at least one fall in the 
preceding twelve months. There was a high rate of fall-related injuries (74 
percent). Factors that were associated with a higher fall frequency included: 
disease duration, severity of ataxia, the presence of pyramidal symptoms, 
the total number of non-ataxia symptoms, and the genotype SCA3. Factors 
associated with a lower fall frequency were: the presence of extrapyramidal 
symptoms (more specifically dystonia of the lower limbs) and the genotype 
SCA2. The total number of non-ataxia symptoms and longer disease duration 
were independently associated with a higher fall frequency in a logistic 
regression analysis, while the presence of extrapyramidal symptoms was 
independently associated with a lower fall frequency. Our findings indicate that, 
in addition to more obvious factors that are associated with frequent falls, 
such as disease duration and ataxia severity, non-ataxia manifestions in SCA 
play a major role in the fall etiology of these patients. 
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Introduction 
Autosomal dominant spinocerebellar ataxias (SCAs) are a group of heredo-
degenerative disorders that mainly affect the cerebellum. These usually 
adult-onset ataxias share features of slowly progressive gait and limb ataxia, 
dysarthria, and abnormal oculomotor control. At present, 27 genetic loci are 
known to be involved in SCAs and 20 of the corresponding genes have been 
cloned.1 The exact pathophysiological mechanisms are yet unresolved and there 
is still no curative treatment. 
 At present, we can only provide supportive care, which aims to prevent 
the functional consequences and complications of the disease. One of these 
major consequences is falling, of which the devastating physical and emotional 
corollaries have been reviewed extensively.2-4 In a recent pilot study, we showed 
that 93 percent of patients with degenerative cerebellar ataxias reported one 
or more falls in the preceding twelve months and many suffered injuries due to 
these falls.5 Because of the relatively small number of patients in that preliminary 
study, specific clinical or genetic characteristics that would allow fall prediction 
could not be extracted.
The ongoing natural history study of SCA patients as embedded in the EuroSCA 
collaborative project provided us with a unique opportunity to study falls in a 
large cohort of fully characterized SCA patients. We sought to investigate the 
frequency, details, and consequences of falls in SCA patients and specifically 
aimed to explore patient and disease characteristics that are associated with 
a high fall frequency. Such data allow us to understand the fall etiology in SCA 
and are also relevant for future interventional efforts and perhaps more tailored 
prevention.
Subjects and methods
Subjects
Patients were recruited from the EuroSCA natural history study, which is a 
European, clinically based, two-year follow-up study in 526 patients with SCA1, 
SCA2, SCA3 or SCA6. At the baseline visit, the ataxia disease stage was 
assessed, while the following scales were applied: the Scale for the Assessment 
and Rating of Ataxia (SARA), the inventory of non-ataxia symptoms (INAS), and 
the Functional Composite score.6-8
 Ten of the seventeen EuroSCA centers participated in this fall study, which 
would result in a maximum sample size of 383 patients. Exclusion criteria 
included: complete loss of ambulation or permanent use of wheelchair, severe 
visual impairment, cognitive disturbances (judged to interfere with obtaining 
informed consent or with recalling previous fall incidents), and orthopaedic 
disorders that affect balance. Relevant disease characteristics per patient were 
retrieved from the EuroSCA registry and included age, gender, age at onset,  
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SCA type, and length of expanded CAG repeat. The database of the natural 
history study provided the baseline SARA score and INAS count. 
 Patients that participated in the EuroSCA natural history study, but not in this 
fall study, will be referred to as ‘non-participants’.
Questionnaire
At the baseline visit of the EuroSCA natural history study, participants were 
asked to complete a modified version of a standard fall questionnaire, which we 
had used in our pilot study and which was previously used in studies on falls in 
Parkinson’s disease and progressive supranuclear palsy.5,9,10 The questionnaire 
was available in Dutch and English, and was translated into German and 
French by local investigators. The questionnaire had to be self-completed, but if 
necessary, patients were assisted by the local research physician. 
 A fall was defined as ‘every event that results in you ending up on the floor 
(or any other lower surface) unintentionally’.10 The questionnaire specifically 
addressed the first fall after disease onset, the frequency of falls within the 
last twelve months, fear of falling, restrictions in daily activities due to the falls, 
measures undertaken to prevent falling, and an estimation of the self-perceived 
confidence in one’s own balance (0: no confidence, 100: full confidence).11 
Participants were also asked about fall-related injuries, fall circumstances and 
directions of falls, but only if they had indicated to have suffered a fall within the 
last month, in order to minimize possible recall bias. Finally, the questionnaire 
also contained questions concerning living circumstances, relevant past medical 
history, the use of walking aids, and the use of medication. Regarding the 
latter, only drugs considered to be psychotropic were documented; these mainly 
included anticholinergics, dopaminergic drugs, benzodiazepines, antidepressants, 
antiepileptic drugs, and antipsychotics.
Data analysis and statistics
Patients were classified as “fallers” if they reported one or more falls in the 
preceding twelve months covered by the questionnaire. In order to derive factors 
that are associated with a higher fall frequency, the study group was divided 
into “non-frequent fallers” and “frequent fallers” prior to data analysis. Those 
who reported to fall never to just once a year were classified as non-frequent 
fallers, those who fell at least once a month were classified as frequent fallers. 
The reason the put both the non-fallers and the participants with one fall into 
the group of ‘non-frequent fallers’, is that one fall in the past 12 months might 
be a chance occassion. For example, in previous studies, 24 percent of healthy 
controls also suffered one fall in a 12-month period.10,11 We therefore found those 
who reported to fall at least once a month to represent a group with clinically 
relevant and likely disease-related falls. To assess ataxia severity we only used 
the SARA total score and the scores of the gait and stance items (SARA1 and 
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SARA2, respectively). To study the influence of non-ataxia symptoms, the INAS 
items were grouped into categories that reflect the various extracerebellar 
systems, e.g. neuropathy or pyramidal tract pathology.
 To study potential selection bias, differences between participants and  
non-participants were tested for significance using unpaired t-tests for age, age 
at onset disease, disease duration, and SARA and INAS total scores. To examine 
possible correlations between the INAS scores and SARA total score, as well as 
other variables, we used bivariate correlations with Spearman’s rho. Chi-square 
and Fisher exact tests were used for variables expressed as proportions. 
 To test the significance of differences between the frequent and non-
frequent fallers, non-parametric testing was used, including the Mann-Whitney 
and Kruskal Wallis tests for numeric data and bivariate correlations with 
Spearman’s rho for proportions. Multiple comparisons between the four different 
genotypes, including age, disease duration, age at onset, and SARA and INAS 
scores, were made using a one-way ANOVA-test. To evaluate whether any variable 
or a combination of variables influenced the frequency of falls, logistic regression 
analysis with Bonferroni correction was carried out on those variables that 
significantly differed between the frequent and non-frequent fallers. Odds ratios 
(OR), and 95% confidence intervals (CI) were calculated.
Results 
From the source population of 383 patients, 234 patients agreed to participate, 
which corresponds to 61.6 percent. Of these 234 patients, four were excluded 
because they were found to be asymptomatic. The questionnaire of two further 
patients was incomplete. Thus, we were able to fully analyse the data from 228 
patients, except for the analysis between the different genotypes for which we 
had to exclude two patients as their genotype could not be confirmed. 
 The EuroSCA registry contained some missing items and we only analysed 
items of the which the data were available for more than half (i.e. 115) of the 
participants, unless specifically stated otherwise.
Study group and baseline characteristics
Participants and non-participants were comparable with respect to gender, 
disease duration, ataxia severity (SARA), and total number of non-ataxia 
symptoms (INAS) (table 1). Participating patients were slightly older than non-
participants and had a slightly higher age at the onset of disease. Also, the 
relative frequencies of the different genotypes in the study group did not match 
those in the group non-participating patients. The proportion of patients with 
SCA6 was significantly higher in the participant group compared to the non-
participant group (table 1). 
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 Compared to the non-participating patients, the participants with SCA1 
had a smaller mean length of the expanded CAG repeat (45.4 ± 5.7 vs. 47.8 
± 5.4, p=0.031), and the participants with SCA3 had larger mean CAG repeat 
expansions (70.6 ± 4.6 vs. 67.9 ± 3.8, p<0.001). There were no such differences 
for SCA2 and SCA6.
 In the group of participants, ataxia severity as expressed by SARA correlated 
with disease duration (r=0.525, p=0.001) and the number of non-ataxia 
symptoms correlated with ataxia severity (r=0.292, p<0.001).
TABLE 1 Baseline characteristics, participants vs. non-participants
RELEVANT BASELINE DETAILS
PARTICIPANTS 
(N = 228)
NON-PARTICIPANTS 
(N = 292) P-VALUE
Age (yr) 52.4 ± 14.1 49.4 ± 14.0 0.008
Age at onset (yr) 41.9 ± 12.8 38.9 ± 13.7 0.009
Men (%) 49.6 54.1 NS
Disease duration (yr) 10.8 ± 6.1 10.3 ± 6.4 NS
SCA1 (%) 17.5 24.9 NS
SCA2 (%) 31.9 29.7 NS
SCA3 (%) 25.8 27.2 NS 
SCA6 (%) 24.9 17.9 0.047
SARA1 ‘Gait’ 4.0 ± 4.7 3.6 ± 2.3 NS
SARA2 ‘Stance’ 2.5 ± 1.6 2.7 ± 1.7 NS
SARA total score 14.9 ± 7.6 15.8 ± 8.3 NS
INAS total score 4.1 ± 2.2 3.8 ± 2.5a NS
The participants came from the actual source population of 383 patients, while for the group of non-participants  
we used the entire EuroSCA cohort minus those who participated.
a Complete documentation available for 71 subjects 
NS = non-significant
Fall Questionnaire
The mean age at onset of the disease was 41.9 ± 12.8 years, and ranged 
from 7 to 77 years (table 1). The majority of the patients lived independently 
(82.6 percent). With regard to potential contributors to falls, 35.0 percent of all 
patients reported to use psychotropic medication. A small proportion of the study 
group had impaired vision (6.2 percent) and 14.3 percent had SCA-unrelated 
musculoskeletal pathology. Less than half of the patients were able to walk 
without support or walking aid (49.3 percent). 
 At least one fall in the preceding twelve months was reported by 73.6 
percent of the patients (table 2). The majority of the patients fell once a year to 
once a month (57.7 percent), 12.3 percent indicated to fall once a week, and 3.5 
percent experienced a fall every day. 
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 The mean estimated interval between disease-onset and the first fall was 
4.6 ± 4.8 years, but ranged from 0 to 25 years, implying that a fall had been 
the presenting feature in some patients (table 2). More than one-third of the 
patients, who had fallen within the last month, fell forwards, backwards or 
sideways equally frequent (37.4 percent), while 47.1 percent mostly fell in the 
anterior-posterior direction and 15.5 percent mostly fell sideways. 
 Of the patients who reported one or more falls in the past month, 73.6 
percent had suffered an injury due to a fall and 22.5 percent had suffered a 
fracture. A fear of falling occurred in 60.3 percent of the patients, and a similar 
proportion avoided activities because of this fear. The mean estimation of the 
self-perceived confidence in one’s own balance was 45.8 (for comparison, in a 
previous study of 82 healthy controls with a mean age of 59.4 ±14.2 years, this 
was 95.4 ± 9.7)5. The majority of patients reported to have taken measures to 
prevent falling, such as using a walking aid or avoiding activities (table 2). 
TABLE 2 Results questionnaire
FALL QUESTIONNAIRE ITEMS
Characteristics
Living independently (%) 82.6
Living alone (%) 16.1
Psychotropic medication (%) 35.0
Antihypertensive medication (%) 27.9
Impaired vision (%) 6.2
Musculoskeletal pathology (%) 14.3
Walking without support (%) 49.3
First fall after onset disease (yr) 4.6 ± 4.8
Fall frequency
Fallers ≤ 12 months (%) 73.6
Fall frequency (%)
- never 26.4
- once a year 35.2
- at least every month, but not every week 22.5
- at least every week, but not every day 12.3
- every day 3.5
Consequences of falling
Injurious fallers (%) 73.6a 
- fracture (%) 22.5a
Fear of falling (%) 60.3
Restriction of activities (%) 57.3
Measures to prevent falls (%) 82.9
Troubled by near-falls (%) 54.8
Self-perceived confidence in balance (0-100) 45.8 ± 28.6
a Expressed as a proportion of the fallers.
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Differences between frequent and non-frequent fallers
The mean disease duration of frequent fallers was longer (table 3). The group 
of frequent fallers contained relatively more SCA3 patients and less SCA2 
patients (table 3). The severity of ataxia, including ataxia of gait (SARA1) and 
stance (SARA2), was significantly greater in the group of frequent fallers. The 
total number of non-ataxia symptoms (INAS count) was higher in the group of 
frequent fallers and the proportion of patients with pyramidal symptoms was 
larger. Contrarily, the percentage of patients with extrapyramidal symptoms was 
smaller (table 3). Upon further study, it became apparent that leg dystonia was 
particularly more common in SCA3 patients who were classified as non-frequent 
fallers (data not shown). 
 Frequent fallers reported more injurious falls and less balance confidence. 
They also used a walking aid or walking support more often than non-frequent 
fallers, and frequent fallers were less often able to go outdoors alone. 
Physiotherapy was given to 29.8 percent of the non-frequent fallers, compared  
to 18.8 percent of the frequent fallers (p=0.186).
TABLE 3 Differences between non-frequent fallers and frequent fallers
ITEM
NON-FREQUENT 
FALLERS 
(N = 141)
FREQUENT  
FALLERS 
(N = 87)
UNIVARIATE 
LOGISTIC 
REGRESSION 
EXP(B) P- VALUE
Age (yr) 52.6 ± 15.1 51.7 ± 12.4 0.995 NS
Men (%) 54.3 42.5 0.633 NS
Age onset of disease (yr) 43.0 ± 13.3 39.7 ± 11.6 0.979 NS
Disease duration (yr) 9.9 ± 15.1 12.3 ± 6.3 1.067 0.001
Genotype (%)
- SCA1 16.5 19.5 1.235 NS
- SCA2 38.1 23.0 0.490 0.020
- SCA3 18.0 36.8 2.551 0.003
- SCA6 27.3 20.7 0.700 NS
Independent living situation (%) 83.6 81.6 0.995 NS
Living alone (%) 16.4 14.9 0.990 NS
Psychotropic medication (%) 33.1 39.1 1.312 NS
Antihypertensive medication (%) 29.4 25.3 0.821 NS
Impaired vision (%) 8.5 2.8 0.311 NS
Musculoskeletal pathology (%) 12.7 16.7 1.287 NS
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ITEM
NON-FREQUENT 
FALLERS 
(N = 141)
FREQUENT  
FALLERS 
(N = 87)
UNIVARIATE 
LOGISTIC 
REGRESSION 
EXP(B) P- VALUE
SARA 1 ‘Gait’ 3.4 ± 2.3 4.9 ± 7.0 1.187 0.001
SARA 2 ‘Stance’ 2.3 ± 1.7 2.7 ± 1.4 1.145 0.038 
SARA total score 14.3 ± 6.6 16.0 ± 6.4 1.032 0.012
INAS ‘Impaired vibration sense’ (%) 66.4 59.7 0.742 NS
INAS ‘Impaired visual acuity’ (%) 5.1 7.2 1.458 NS
INAS ‘Pyramidal’ (%) 37.5 59.5 2.480 0.002
INAS ‘Neuropathy’ (%) 38.7 49.4 1.566 NS
INAS ‘Ophthalmoparesis’ (%) 47.1 48.8 1.088 NS
INAS ‘Extrapyramidal’ (%) 9.5 1.2 0.232 0.020
INAS total score 3.7 ± 2.0 4.9 ± 2.4 1.299 0.001
First fall after onset disease (yr) 4.9 ± 4.8 4.3 ± 4.9 0.976 NS
Measures to prevent falls (%) 82.5 83.1 0.954 NS
Injurious fallers (%)a 61.4 83.3 1.938 0.008
Walking without support (%) 58.1 35.6 1.952 0.003
Fear of falling (%) 56.5 65.5 1.373 NS
Restriction of activities (%) 53.7 62.1 1.319 NS
Troubled by near-falls (%) 47.7 65.1 1.530 0.000
Confidence in balance (0-100) 52.5 ± 29.0 35.4 ± 25.3 0.978 0.000
a Expressed as a proportion of the fallers.
NS non-significant
Differences between genotypes
Relatively more SCA3, followed by SCA1, patients were classified as frequent 
fallers. Yet, the different SCA types were comparable with respect to disease 
duration, SARA1, SARA2 and SARA total scores, as well as to the INAS 
items ‘impaired vibration sense’, ‘impaired visual acuity’, and ‘extrapyramidal 
symptoms’ (Table 4). However, in SCA1 and SCA3, pyramidal features were much 
more frequent than in SCA2 and SCA6. SCA3 patients also had the highest 
frequency of neuropathy and ophthalmoparesis. The SCA6 patients were older, 
had a later age at onset, and had the lowest INAS count. 
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TABLE 4 Results of multiple comparisons between the four genotypes 
ITEM SCA1
(N = 40)
SCA2
(N = 72)
SCA3
(N = 59)
SCA6
(N = 57) P- VALUE
Age (yr) 51.2 ± 11.4 48.6 ± 15.3 48.6 ± 11.8 63.0 ± 11.2 <0.001
Disease duration (yr) 10.8 ± 6.4 10.3 ± 5.6 11.3 ± 6.4 10.8 ± 6.1 NS
Age onset disease (yr) 40.5 ± 9.9 38.3 ± 12.5 37.1 ± 12.0 52.6 ± 9.7 <0.001
Frequent fallers (%) 42.5 27.4 56.1 32.1 0.006
SARA1 ‘Gait’ 3.8 ± 2.5 3.2 ± 1.9 5.1 ± 8.5 3.9 ± 1.9 NS
SARA2 ‘Stance’ 3.0 ± 2.1 2.5 ± 1.4 2.2 ± 1.4 2.3 ± 1.5 NS
SARA total score 16.9 ± 10.5 14.6 ± 6.7 13.8 ± 6.7 15.1 ± 6.9 NS
INAS ‘Impaired vibration sense’ (%) 62.2 66.2 71.7 53.7 NS
INAS ‘Impaired visual acuity’ (%) 8.6 7.9 4.5 2.2 NS
INAS ‘Pyramidal’ (%) 66.7 31.0 63.2 31.5 <0.001
INAS ‘Neuropathy’ (%) 35.0 46.5 60.6 23.6 <0.001
INAS ‘Ophthalmoparesis’ (%) 40.0 33.8 64.3 51.9 0.005
INAS ‘Extrapyramidal’(%) 0 7.0 10.5 5.5 NS
INAS count 5.2 ± 2.2 4.3 ± 1.8 4.9 ± 2.4 2.4 ± 1.4 <0.001
NS non-significant
Logistic regression 
The variables disease duration, genotype, SARA1, SARA2, SARA total score, INAS 
count, INAS ‘pyramidal symptoms’, and INAS ‘extrapyramidal symptoms’ were 
entered into a logistic regression model. Stepwise forward logistic regression 
analysis showed that disease duration and the number of non-ataxia symptoms 
were significantly associated with a higher fall frequency. For disease duration 
(per year): odds ratio 1.07, confidence interval 1.01-1.13, p=0.029; for the 
number of non-ataxia symptoms (per INAS count): odds ratio 1.35, confidence 
interval 1.12-1.63, p=0.002. The presence of extrapyramidal symptoms was 
significantly associated with a lower fall frequency (odds ratio 0.07, confidence 
interval 0.01-0.76, p=0.028). 
Discussion 
Falls have been studied extensively in patients with neurological diseases, such 
as Parkinson’s disease, progressive supranuclear palsy, and neuromuscular 
diseases.2-4,9-13 Little is known about falls in patients with hereditary cerebellar 
ataxias. In 2005, a pilot study was conducted in 42 patients with late-onset 
degenerative cerebellar ataxias, and the results indicated that falls are frequent 
and often injurious in these patients.5 However, this study group was too small to 
derive specific factors that are associated with a higher fall frequency. Such data 
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are relevant, not only for obvious clinical purposes, but also to gain more insight 
into the causes of falling in these patients. 
In this fall study, as part of the ongoing EuroSCA natural history study, 74 percent 
of the patients reported at least one fall in the past twelve months. In most 
patients, falls occurred in an early disease stage (often within the first two years 
of disease) and were even the presenting feature in 10 percent. The majority 
of the patients fell in the anterior-posterior direction, which corresponds to a 
previous study that examined trunk sway in SCA patients that demonstrated more 
anterior-posterior than lateral postural instability during everyday stance and 
walking tasks.14
Our study showed that falls often have major consequences for SCA patients, 
including (severe) injuries and avoidance of activities due to a fear of future 
falls. Factors that predicted a higher frequency of falls in the whole study group 
were disease duration, severity of ataxia, the INAS count (i.e. number of non-
ataxia symptoms), the presence of pyramidal features, and the genotype SCA3. 
Contrary to other fall studies, psychotropic medication did not influence the 
frequency of falls.12,13,15 We were not able to study the potential influence of 
spasmolytic drugs as the number of patients on these agents was too low. The 
genotype SCA2 and the presence of extrapyramidal symptoms were associated 
with a lower fall frequency. 
 The genotype SCA3 was identified to be one of the factors associated with a 
higher fall frequency. Indeed, frequent fallers were more common amongst SCA3 
patients, while the four different genotypes were comparable with respect to 
disease duration and severity of ataxia. Interestingly, the total number of non-ataxia 
symptoms was highest in the SCA3 and SCA1 groups and pyramidal features in 
particular were much more frequent in these subtypes. The relevance of pyramidal 
features is also evident from the fact that within the SCA6 group, frequent fallers 
were observed to have more pyramidal tract involvement (data not shown).
In a logistic regression analysis, the disease duration and the number of non-ataxia 
symptoms were independently associated with a higher fall frequency. The number 
of non-ataxia symptoms, ataxia severity and disease duration were all interrelated, 
and the number of non-ataxia symptoms was also significantly different for the 
various genotypes. This might in part explain why INAS count and disease duration 
were identified by logistic regression analysis as a contributing factor, and ataxia 
severity was not.Given the clinical heterogeneity of the SCAs, in particular SCA3, it 
was not unexpected that the logistic regression analysis did not point to a certain 
genotype as predictive but rather to associated disease features.
 The presence of extrapyramidal features was correlated with a lower fall 
frequency in the logistic regression analysis. Considering these extrapyramidal 
symptoms, of which the overall prevalence was low, particularly dystonia of the 
lower limbs was responsible for the significant difference between frequent 
FALLS, PHYSIOTHERAPY AND TRAINING IN PATIENTS WITH CEREBELLAR DEGENERATION 39
and non-frequent fallers. Leg dystonia was mostly observed in SCA3 patients 
within the group of non-frequent fallers, and not present in SCA1 patients, SCA6 
patients, nor in the total group of frequent fallers (data not shown). Upon further 
analysis of the data, however, it was apparent that pyramidal features were less 
prevalent in those with dystonia (20 percent) than in those without dystonia (46.1 
percent). So although extrapyramidal features came out as a separate factor in 
the logistic regression analysis, this might largely be explained by the absence 
of pyramidal features. The presence or absence of dystonia was not related to 
disease duration or age at onset.
 We are not aware of any fall study in patients with primary or secondary 
dystonia, but it would be interesting to see whether falls are indeed less common 
in this movement disorder compared with other neurological diseases.
The results of our study should be interpreted in the context of several 
limitations. The first is the retrospective nature of this questionnaire study. This 
might have introduced a recall bias, with an underreporting or overestimation 
of falls. Still, the basic results of this study are to a large extent biologically 
plausible. Second, the questionnaire was not available in all languages and 
the local investigators had to translate the questions for the patients in some 
centers. That might have led to a slightly different interpretation of the various 
questions. Third, there was no full match between the participating and non-
participating SCA patients, as there were some differences in age, age at onset, 
relative SCA frequencies, and CAG repeat expanion in SCA1 and SCA3. It is 
however difficult to speculate how these differences might have influenced our 
results, as sufficient matching was obtained for disease duration, ataxia severity, 
and total INAS count. Finally, the current EuroSCA natural history study does not 
include detailed neuropsychological evaluations and the potential influence of 
cognitive dysfunction might hence have remained unrecognized.
We conclude that falls are very common in SCA patients and that falls have major 
consequences for these patients. For SCA patients in general, disease duration, 
the severity of ataxia, the total number of non-ataxia symptoms, and the presence 
of pyramidal symptoms seem to predict a higher fall frequency. Patients with 
extensive extracerebellar pathology and, more specifically, frequent pyramidal 
tract involvement (such as in SCA3 and SCA1) are more prone to fall. It is yet 
unclear how to translate these findings to the clinical practice i.e. to the individual 
SCA patient. However, in the design of fall intervention trials in SCAs, which are 
currently initiated, these contributory factors should be taken into account.
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Abstract
In a previous retrospective study, we demonstrated that falls are common and 
often injurious in the dominant spinocerebellar ataxias (SCAs) and that non-
ataxia features play an important role in these falls. Retrospective surveys 
are plagued by recall bias for presence and details of prior falls. We therefore 
sought to corroborate and extend these retrospective findings by means of a 
prospective extension of this fall study. 113 patients with SCA1, SCA2, SCA3 
or SCA6, recruited from the EuroSCA natural history study, were asked to 
keep a fall dairy in between their annual visits to the participating centres. 
Additionally, patients completed a detailed questionnaire about the first three 
falls, to identify specific fall circumstances. Relevant disease characteristics 
were retrieved from the EuroSCA registry. 84.1 percent of patients reported 
at least one fall during a time period of 12 months. Fall-related injuries were 
common and their frequency increased with that of falls. The presence of 
non-ataxia symptoms was associated with a higher fall frequency. This study 
confirms that falls are a frequent and serious complication of SCA, and that 
the presence of non-ataxia symptoms is an important etiological factor in its 
occurrence.
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Introduction
The autosomal dominant spinocerebellar ataxias (SCAs) are a heterogeneous 
group of usually adult-onset diseases. In addition to the progressive cerebellar 
syndrome, a broad spectrum of other neurological features can manifest.1 
As these diseases are currently untreatable, care for these patients is purely 
supportive and should aim at detecting and preventing functional complications 
as much as possible. One of the more common complications is falling. In a 
recent retrospective study that was part of the EuroSCA project, we found that 
falls were reported by almost 75 percent of patients and that these falls often led 
to injuries. We identified several determinants of falls, including disease duration 
and ataxia severity, but also the so-called non-ataxia features and in particular 
the presence of pyramidal signs.2 We here wish to confirm these findings by 
means of a prospective fall study, which also allowed us to comment on the 
validity of the instruments used to examine falls.
Subjects and methods
Subjects
A total of 113 patients with SCA 1, 2, 3 or 6 recruited from the EuroSCA natural 
history study, were included. The remaining 416 patients within the EuroSCA 
study formed the group of “non-participants” and were used for comparative 
analyses.3 Relevant disease characteristics, scores on the scale for the 
assessment and rating of ataxia (SARA) and scores on the inventory of non-
ataxia symptoms (INAS) for each patient were retrieved from the EuroSCA 
registry.4, 5 The SARA rates only ataxia-related symptoms, with higher score 
indicating worse performance (0-40). The INAS is a clinical checklist of non-
ataxia symptoms. The INAS count reflects the number of non-ataxia symptoms 
in each patient. To determine the INAS count, the INAS is transformed into a set 
of 16 binary (yes/no) variables (hyperreflexia, areflexia, extensor plantar reflex, 
spasticity, paresis, muscle atrophy, fasciculations, myoclonus, rigidity, chorea/
dyskinesia, dystonia, resting tremor, sensory symptoms, urinary dysfunction, 
cognitive dysfunction, and brainstem oculomotor signs). Higher scores thus 
indicate the presence of more non-ataxia symptoms. 
 The degree of mobility was derived from the questionnaires used for the 
retrospective part of the EuroSCA fall study.2 Approval for this study according to 
local regulations was obtained in every participating centre and all patients gave 
informed consent for participation.
Fall diary and fall registration form 
At their visit to the participating centre, patients were asked to start documenting 
falls and near-falls on a fall diary and to hand it in at the next visit. They were also 
instructed to fill in standarized fall registration forms for the first three falls or  
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near-falls. A near-fall was defined as ‘losing your balance but managing to stay 
upright, for example by holding on to something’. The forms had to be self-completed, 
but if necessary, patients were assisted by the local research physician. In the fall 
diary patients had to fill in the date of the (near) -fall, the direction of falls, cause 
and fall-related injuries. The fall registration forms contained questions about 
the fall circumstances, including the time, location, assumed cause of the fall, 
injuries and whether assistance was needed to get up.6, 7 
 
Data analysis and statistics
Analysis of the data with the Shapiro-Wilk test showed that the data were not 
normally distributed.
 Patients were classified as ‘fallers’ if they reported one or more fall in the fall 
diary or fall registration forms. In order to derive factors that are associated with 
a higher fall frequency, the study group was divided into four groups, depending 
on their fall frequency. The reported fall frequencies were classified as ‘never’, 
‘annually’, ‘monthly’ and ‘weekly’. The reason the groups ‘never’ and ‘annually’ 
were not combined to one group, is that some patients reported more than one 
fall in a year, but not enough falls to categorize the frequency of falls as ‘monthly’.
 To assess ataxia severity, we only used the SARA total score and the scores 
of the gait and stance items. To study the influence of non-ataxia symptoms, we 
used the INAS count and the INAS items ‘impaired vibration sense’ and ‘cognitive 
symptoms’, while the other items were grouped into categories other than the 
existing INAS count categories, which reflected the various extracerebellar 
systems: ‘extrapyramidal’ (dystonia, rigidity, chorea), ‘pyramidal’ (hyperreflexia, 
spasticity, paresis) and ‘impaired vision’ (impaired visual acuity, double vision, 
ophthalmoparesis).2
 To test for significance of differences between participants in this 
prospective fall study and non- participants, and between the patients grouped 
according to their fall frequency, we used the Mann-Whitney and Kruskal Wallis 
tests for numeric data and Chi-square and Fisher exact tests for proportions. 
Bivariate correlations with Spearman’s rho was used to examine possible 
relations between fall frequency, the INAS count, total SARA score, disease 
duration, age, and age at the onset of disease. 
Results
Study group and baseline characteristics
Baseline characteristics of the study population are summarized in table 1. 
Participating patients were somewhat older than non-participants and had a 
higher age at the onset of disease. Also, the proportion of patients with SCA6 
was significantly higher in the participant group, which probably explains the 
slightly higher onset age in that group. 94.7 percent of the participants also 
participated in the retrospective study, and only 34.4 percent of these patients 
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were able to walk without support (table 1).
 In the group of participants, ataxia severity (SARA total score) correlated  
with disease duration (r=0.600, p= < 0.001), but only weakly with age (r=0.242,  
p= 0.010) and the number of non-ataxia symptoms (INAS count; r=0.247,  
p= 0.049). The number of non-ataxia symptoms negatively correlated with the 
onset age (r= -0.384, p= 0.002) and age (r= -0.341, p= 0.006). Fall frequency 
was only correlated with the number of non-ataxia symptoms. (INAS count, 
r=0.300, p= 0.048). 
TABLE 1 Baseline characteristics, participants vs. non-participants
FREQUENCY OF FALLS
ITEM
ALL PAR-
TICIPANTS
(N=113)
NEVER
(N=27)
ANNUALLY
(N=24)
MONTHLY
(N=28)
WEEKLY
(N=3)
P- VALUE
Age (yr) 56.0±14.7 58.5±15.4 60.3±13.6 55.0±14.4 49.0±10.6 NS
Men (%) 49.6 63.0 41.7 57.1 66.7 NS
Disease duration (yr) 11.8±6.4 10.5±7.2 13.5±6.5 11.6±5.8 8.3±0.6 NS
Age onset disease (yr) 43.9±13.0 47.6±13.5 46.4±10.8 43.0±13.6 40.7±10.2 NS
SARA 1 ‘Gait’ 3.7±2.1 3.6±2.8 3.7±1.8 3.4±1.5 4.3±1.5 NS
SARA 2 ‘Stance’ 2.6±1.7 2.5±2.1 2.6±1.6 2.6±1.5 2.3±0.6 NS
SARA total score 15.6±7.7 15.3±10.2 15.6±5.5 15.0±5.9 12.7±1.2 NS
INAS ‘Impaired vibration sense’ (%) 53.5 62.5 59.1 59.3 50.0 NS
INAS ‘Impaired vision’ (%) 26.6 12.0 30.4 14.8 33.3 NS
INAS ‘Cognitive symptoms’ (%) 21.8 24.0 4.3 21.4 0 NS
INAS ‘Pyramidal symptoms’ (%) 45.0 28.0 34.8 39.3 66.7 NS
INAS ‘Extrapyramidal symptoms’ (%) 10.9 8.0 8.7 14.3 0 NS
INAS counta 3.8±2.4 2.4±1.5 4.0±2.0 3.6±2.5 7.5±2.1 0.040
Genotype (%) NS
- SCA1 19.5 22.2 20.8 25.0 0
- SCA2 25.7 29.6 20.8 17.9 33.3
- SCA3 20.4 11.1 25.0 17.9 66.7
- SCA6 34.5 37.0 33.3 39.3 0
Mobility (%)b NS
- Walking without support 34.3 50.0 36.4 25.9 0
-  Walking with the use of a walking aid 49.5 27.3 50.0 59.3 66.7
-  Walking with the assistance of others 9.5 0 9.1 14.8 33.3
-  Walking is impossible/ wheelchair 6.7 22.7 4.5 0 0
Falls each month 0.7±0.9 0 0.3±0.1 0.9±0.4 3.9±1.5 < 0.001
Near falls each month 8.2±32.6 2.6 ±2.8 16.2± 52.4 2.8 ±6.4 10.8 ±7.5 0.045
Injurious fallers (%) 54.7 10.0 62.5 82.1 100 < 0.001
a Complete documentation available for 64 of all subjects and 44 subjects in which the fall frequency is calculated.
b  Results of the retrospective EuroSCA Fall Study, available for 105 of all subjects and 74 subjects in which the fall 
frequency is calculated.
NS non-significant
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Fall diary and registration forms
The majority of the patients (83.3 percent) completed the fall registration forms, 
and 85 subjects (75.2 percent) returned a fall diary. Some fall diaries did not 
mention the end date; in those patients, the date of the last documented fall was 
used as the end date. In three patients it was not possible to determine the time 
period of the fall diary. Some patients kept the diary for a much longer time period, 
resulting in a time period ranging from 1 to 44 months covered by the diaries. 
At least one fall was reported by 84.1 percent of the patients. In total 345 falls 
were reported. The average fall frequency was 0.68 falls each month. One third 
of the patients who had returned the fall diary could be categorized in the group 
‘annually’, and a slightly larger group reported to fall monthly. Only 3.7 percent fell 
once a week, and none of the patients experienced falls every day. Near-falls were 
reported by 76.2 percent of the patients, with an average of 8.2 each month. 
 Of all 113 participants, 54.7 percent reported some kind of injury due to a 
(near-)fall, mainly bruises (table 1). Three times, a fracture was reported. Almost 
two-thirds of the patients fell in the anterior-posterior direction, without any 
difference between forwards or backwards. The majority of the falls occurred 
indoors. For each fall documented in the fall diary, a cause was noted. The 
majority of the fallers (74.2 %) listed loss of balance to be the causative factor, 
followed by tripping (27.0 %) and slipping (18 %). Other causes varied from 
hastiness, vertigo and changing direction (table 2).
TABLE 2 Details of each reported fall
ITEM
Indoors (%) 69.9
Familiar environment (%) 80.3
Unexpected (%) 62.2
Direction of fall (%) 63.0
- Sideways 35.6
- Forwards 32.2
- Backwards 32.2
Assistance needed to get up (%) 28.2
Reported cause (%)
- Loss of balance 74.2
- Tripping 27.0
- Slipping 18.0
- Dizziness 4.5
- Changing direction 7.9
- Uneven floor 5.6
- Hastiness 9.0
- Other cause 24.7
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Differences between the fall frequency groups
The differences between the groups with a different fall frequency are 
summarized in table 1. There was a significant difference in the INAS count 
between the various fall frequency groups. The percentage of patients who 
reported injuries was correlated with increased frequency of falls. The patients 
who reported to fall annually, reported the highest number of near-falls. There 
were no other significant differences. 
Discussion 
This prospective analysis of falls confirms that in SCA patients falls are a 
frequent and serious complication. Also, the number of non-ataxia symptoms was 
again identified as a relevant determinant of a higher fall rate. 
 Contrary to our previous retrospective study, which included 228 patients, 
we could not corroborate that the presence of pyramidal features was the most 
relevant component among the non-ataxia features.2 However, pyramidal signs 
showed a tendency for higher prevalence in frequent fallers (table 1). Similarly, 
while we previously showed that disease duration, ataxia severity and the SCA3 
genotype were positively associated with a higher frequency of falls, the current 
data did not reveal this. The mostly likely explanation is the reduced power to 
pick up such effects due to the smaller sample size. In addition, the composition 
of the group of patients participating in the present study was slightly different, 
with relatively more SCA6 patients, in whom non-ataxia symptoms are not only 
less prevalent overall but, in contrast to SCA1, 2 or 3, do not seem to increase 
with disease duration or progression of ataxia.5 As the picture arises that falls 
are less frequent in those with later-onset, uncomplicated disease, such as 
SCA6, this might have influenced the results. With respect to the relation of falls 
with disease duration, our previous finding of falls as one of the first symptoms 
of disease in a considerable number of SCA patients already pointed to the 
weak association with disease duration in this patient group.2 This might be in 
support of the notion that factors other than ataxia contribute to falls, and also 
implies that assessment of falls and near falls is important for counseling of SCA 
patients in any disease stage. 
 There were some further differences between the results of the retrospective 
and the present prospective study. Compared to the retrospective data, more 
patients reported at least one fall in the fall diary (73.6 vs. 84.1 percent), but 
the overall fall frequency was lower. Also, in the prospective study, a lower 
frequency of near-falls was documented and a smaller proportion of the patients 
reported injuries in the fall diary. This might indicate that patients overestimate 
the frequency of falls and injuries retrospectively, or underreport (near-)falls and 
injuries in the fall diaries. Comparison of the fall diaries with the retrospective 
data at the individual level, which was possible for those who participated in 
both studies (n=107), showed that 40.3 percent of the patients documented 
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a lower fall frequency and 25.8 percent documented a higher fall frequency in 
the fall diary. Some fall diaries did not mention the end date; in those patients, 
the date of the last documented fall was used as the end date, but as the 
period actually covered by the diary might have been longer this could have led 
to an overestimation of falls. Secondly, some of the diaries were incomplete, 
in particular for near-falls. On several fall diaries, patients wrote that they 
experienced many near-falls each day, even up to 20, but they did not document 
each of them in the fall diary, causing an underestimation of the frequency of 
near-falls.
 Although these differences and issues have not affected the main messages 
of the two fall studies, they do lead to questions with regard to the validity and 
applicability of the instruments used here to assess falls. This is particularly 
relevant as falls could serve as a secondary outcome in future trials, which 
warrants an accurate measurement of falls. The use of an automated fall 
telephone system would be a more preferable method for this purpose.8
 Although not significant, the mobility data in table 1 suggest that the fall 
frequency goes down once the patients reach the state of wheelchair dependency 
or complete immobility. The patients who reported to fall about once a year in the 
fall diaries, reported the most near-falls (table 1). This may indicate that loss of 
balance leads to actual falls in the more frequent fallers, while others manage 
to keep their balance and have many near-falls. This latter group is important 
to recognize in the clinical setting as they could potentially benefit most from 
balance training and fall prevention programs, although this requires formal 
confirmation.9
 Lastly, the fact that the majority of falls occurred indoors, is a point worth 
considering by rehabilitation physicians, physiotherapists, occupational therapists 
and caretakers. 
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Abstract
Many patients with cerebellar ataxia have serious disabilities in daily life, 
while pharmacological treatment options are absent. Therefore allied health 
care is considered to be important in the management of these patients. 
The objectives were to evaluate scientific evidence for allied health care 
in cerebellar ataxia, to identify effective treatment strategies, and to give 
recommendations for clinical practice and further research. We conducted a 
systematic search for clinical trials concerning allied health care in cerebellar 
ataxias using electronic databases of PubMed, Medline, Embase, Cinahl 
and Pedro, and references lists of articles, in the time period from 1980 
up to and including December 2011 in English and Dutch. We identified 14 
trials, of which the 4 best studies were formally of moderate methodological 
quality. There was a wide variation in disease entities and interventions. The 
combined data indicate that physical therapy may lead to an improvement 
of ataxia symptoms and daily life functions in patients with degenerative 
cerebellar ataxia (level 2), and in other diseases causing cerebellar ataxia 
(level 3). When added to physical therapy, occupational therapy might 
improve global functional status, and occupational therapy alone may 
diminish symptoms of depression (level 3). There are insufficient data for 
speech and language therapy. Therefore, despite the widespread use of allied 
health care interventions in cerebellar ataxia, there is a lack of good quality 
studies that have evaluated such interventions. We found some support for 
the implementation of physical therapy and occupational therapy, but more 
research is needed to develop recommendations for clinical practice. 
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Introduction
Ataxia is a neurological symptom that is characterized by loss of coordination 
of movements. The term cerebellar ataxia is used to indicate ataxia that is due 
to dysfunction of the cerebellum, which leads to disturbances in gait, balance 
and coordination, dexterity, eye movements, and speech. Ataxic gait is associated 
with falls and limitations in daily life.1-4 Despite the known impairments in practice-
dependent and adaption motor learning 1, 5-10, patients with damage of the cerebellum 
are capable of learning new strategies and to compensate for the deficits.3, 5, 11
 There are many causes for cerebellar ataxia, but a challenging group are 
the degenerative cerebellar ataxias. These are progressive, mostly untreatable 
disorders and lead to serious deterioration of mobility, independence, and quality 
of life.12, 13 For many patients with ataxia, regardless of the cause, there are no 
pharmacological treatment options. Patients are often referred for allied health 
care interventions, which are considered the cornerstone in further management. 
Physical therapy, speech therapy, and occupational therapy are expected to prevent 
secondary complications and minimize dependency in daily life in patients with 
ataxia. However, despite the common use of allied health care, there is an unclear 
scientific status with regard to the effectiveness of these interventions and a 
lack of evidence-based treatment guidelines. This obviously results in a marked 
heterogeneity of treatments that patients with this movement disorder receive. 
 As a first step towards a more evidence-based practice, we systematically 
evaluated the evidence for allied health care interventions in cerebellar ataxia.
Methods
Search strategy
A systematic search was performed in the electronic databases of PubMed, Medline, 
Embase, Cinahl and Pedro. Clinical trials were identified using a combination of 
the following terms and MeSH terms: cerebellar ataxia; ataxia; physiotherapy; 
physical therapy; training; exercise; rehabilitation; allied health care; speech therapy; 
language therapy; voice therapy; and occupational therapy. The selected time period 
was January 1st 1980 to December 31st 2011, and the articles had to be published 
in English or Dutch. The retrieved articles were examined for useful references. 
Selection 
Articles were included if they were prospective clinical trials evaluating the 
effectiveness of an allied health care intervention (i.e. physical therapy, speech 
and language therapy, or occupational therapy) in patients with cerebellar ataxia, 
without interfering co-morbidity. The interventions and outcome measures had 
to be clearly defined in the article. Studies assessing patients both with and 
without cerebellar ataxia were only included if individual data for the patients with 
cerebellar ataxia could be extracted. Case reports or series were considered if at 
least two different studies described the same treatment methods.
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Evidence grading
The selected articles were assessed by two of the authors (EF, SK) and the 
findings of the studies were extracted and summarized. Both the quality of the 
study design and the conclusions were appraised according to the classification 
of the levels of evidence using the EBRO classification (table 1) of the Dutch 
Cochrane Centre and the Dutch Institute for Healthcare Improvement (CBO), 
member of the Guidelines International Network (GIN).14 In case of disagreement, 
a third author (BvdW) was consulted to reach consensus. 
 Due to a substantial heterogeneity between the included studies concerning 
disease entities, treatment goals, interventions, follow-up period, and outcome 
measures, a meta-analysis could not be performed.
TABLE 1 The EBRO classification
CLASSIFICATION OF METHODOLOGICAL QUALITY OF INDIVIDUAL STUDIES
A1 Systematic review of at least two independently conducted clinical studies at quality level A2.
A2 Randomized double-blind controlled studies of good methodological quality, sufficient power and 
consistency.
B Comparative studies, not reaching the criteria for A2, including studies with retrospective or patient-
control group study design.
C Non-comparative study design/patient series.
D Expert opinion.
CLASSIFICATION OF THE LEVEL OF SCIENTIFIC EVIDENCE 
1 Conclusion based on a systematic review at quality level A1 or at least two independently conducted 
clinical studies at quality level A2.
2 Conclusion based on a quality level A2 study or at least two independently conducted clinical 
studies at quality level B.
3 Conclusion based on a study at quality level B or C.
4 Conclusion based on expert opinion.
Results
An overview of the literature search is shown in figure 1. Up to 409 references 
per database search were found, of which 33 articles were selected. In addition, 
5 articles were identified through reference lists. Two articles described the 
same study, and were considered as one publication.15, 16 Of these selected 37 
publications, 11 were excluded because of the pre-defined selection criteria. Four 
studies were excluded because of a retrospective study design17-20, three due to 
possible interfering co-morbidity21-23, and one for not describing which interventions 
were used.24 One study was excluded since the effect of the intervention was only 
observed at baseline; the follow up period was evaluated by telephone, with no 
monitoring of the activities of the participants.25 We were not able to obtain the full 
text of two articles.26, 27 Of the remaining 26 studies, 3 did not involve training,  
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but focused solely on a purely measurable kinematic effect of single interventions, 
and were excluded for that reason.28-30 Of the 13 selected case reports31-43, only 
four could be paired because of similar treatment methods.32, 35, 38, 39 
Finally, 14 studies remained, of which 7 studies with five or more subjects 
with cerebellar ataxia.15, 16, 44-49 Only four studies could be classified as level B 
methodological quality, i.e. they included a control group instead of only using 
within-patient comparisons.16, 44, 47, 49 Of these 4 studies, 3 used randomization 
either for the whole or for a part of the intervention44, 47, 49 and 3 involved a 
blinded assessor.16, 44, 47 A summary of the selected articles with at least five 
subjects is given in a supplementary table, Online Resource 1. The included 
studies were heterogeneous with respect to diagnosis, interventions and 
outcomes. The interventions focused on several cerebellar impairments and 
limitations in daily life, and varied in frequency, duration and types of exercises. 
PubMed
Medline
Embase
Cinahl
Pedro
0-409 per search
37 studies*
7 studies
n = ≥ 5
3 case studies
n = 2-4
4 case reports
n = 1
3 intraindividual 
control design
4 studies with
control group
Selection relevant articles
Removal of duplicates
Removal of retrospective studies (n=4)
Exclusion based on comorbidty (n=3)
Full text unavailable (n=2)
No description of intervention (n=1)
No adequate follow-up (n=1)
9 case reports
different interventions
26 studies
3 studies
single intervention
FIGURE 1 Flow diagram of literature search
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Physical therapy
Thirteen studies evaluated the effects of physical therapy 15, 16, 25, 32, 35, 38, 39, 44-47, 49-52, 
of which two in combination with occupational therapy.16, 47 Of these, six included 
at least 5 subjects.15, 16, 25, 44-47, 49 Four of these studies could be classified as 
methodological quality level B (Online Resource 1).16, 44, 47, 49 Physical therapy 
often focused on more than one domain, e.g. gait, balance, coordination, posture 
and muscle strengthening. Interventions applied consisted of conventional 
physical therapy exercises, computer assisted training, treadmill training, and 
biofeedback therapy. 
Conventional physical therapy exercises
Conventional physical therapy targets at least one of the following domains: 
balance, gait, coordination, strength, endurance, and posture. In the majority of 
physical therapy interventions, aids (e.g. a cane or a walking frame) and physical 
therapy equipment (e.g. a balance ball, weights or a treadmill) were used.
 In a study combining physical therapy with occupational therapy in 42 
patients with degenerative cerebellar ataxia, physical therapy, with a focus on 
balance, gait, general condition, muscle strength and range of motion, led to a 
reduction of ataxia severity and fall frequency, and an improvement of gait speed 
and activities of daily living (ADL), compared to half of the patients (n=21) who 
received the same treatment 4 weeks later. The improvement was more prominent 
in trunk ataxia than in limb ataxia. Within-patient comparisons were used to 
analyse long-term effects, and showed that patients with mild ataxia severity 
experienced a more sustained improvement. In more than half of the participants, 
improvement of at least one item was maintained after half a year.47 Another 
study in patients with degenerative cerebellar ataxia, including 10 patients with 
predominant effects on the cerebellum and 6 patients with predominant afferent 
ataxia, used coordinative training with the main goal to activate and engage 
control mechanisms for balance control and multi-joint coordination. Significant 
improvements in ADL and in gait and balance parameters, as well as a reduction 
of ataxia severity were seen after 4 weeks of training, compared to baseline. 
Training effects were more distinct for patients with intact afferent pathways. 
Improvements in motor and ADL performance persisted after one year and 
seemed to be influenced by training intensity at home.15, 46 Training balance, gait, 
and muscle strength in 5 patients with chronic ataxia due to traumatic brain injury, 
led to an improvement in functional independence for gait.45 
 A study in 26 patients with ataxia due to multiple sclerosis (MS), combined 
coordination exercises, gait training, balance training, and vestibular exercises. 
Significant differences were found in sensory test scores, anterior balance, gait 
parameters, diadochokinesis, equilibrium coordination tests, and Expanded 
Disability Status Scale (EDSS), compared to baseline. Limb ataxia was more 
resistant to physical therapy than trunk ataxia. Use of Johnstone Pressure Splints 
in addition to exercise was of no further benefit.44 
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 One study in 37 MS patients with ataxia found that physical therapy 
with weighting, together with occupational therapy, resulted in improvement 
of functional ability concerning ADL tasks, fatigue, and physical functioning, 
compared to patients (n=9) who did not receive any intervention. The physical 
therapy was focused on promoting normal posture and movement using weight 
bearing, damping and weighting, joint approximation and compression, and 
stimulating automatic equilibrium reactions using a gymnastic ball.16 
Treadmill training
Treadmill training in two patients with ataxia due to traumatic brain injury 
improved gait and balance parameters.52 Locomotor training using bodyweight 
support on a treadmill and over-ground walking in a patient with traumatic 
brain injury lead to improvement of balance, gait parameters, motor tasks and 
isometric trunk endurance tests.35 In a child with severe ataxia after a cerebellar 
infarct, bodyweight support on a treadmill and during over-ground walking 
improved her walking and transfer abilities.32 
Relaxation and biofeedback therapy
Three articles suggested a positive effect of biofeedback therapy in patients with 
ataxia.38, 39, 50 In case series using electromyogram (EMG) biofeedback in three 
patients with ataxia due to multiple sclerosis and degenerative cerebellar ataxia, 
subjects were able to reduce the amount of inappropriate coactivation of muscles 
groups.50 Relaxation and EMG biofeedback decreased severity of ataxic tremor in 
two case reports with patients with traumatic brain injury.38, 39 
Computer-assisted training
Improved coordination of the upper limbs after training with adaptive robot 
therapy was suggested in a study of 8 MS patients with ataxia of the upper limbs. 
The training consisted of performing planar reaching movements while grasping a 
handle of a robotic manipulandum, which generated forces that either reduced or 
enhanced the curvature of the movements.49 
Supervised sports
One study noticed that patients showed improvement of velocity and speed 
symmetry in pointing movements of limbs, balance and manual dexterity after 
climbing training. The four participants suffered from upper and lower limb ataxia 
due to different acquired causes.51 
Occupational therapy
One study assessed the use of occupational therapy for cerebellar ataxia.48 
Another two evaluated its use combined with physical therapy.16, 47 In one study, 
26 patients with SCA3 were treated with occupational therapy alone, using the 
rehabilitative compensatory model.53 Hamilton scores for depression improved, 
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but disability scores and quality of life scores remained stable. Therapy was 
adjusted to the needs of the patients.48 
 Occupational therapy, combined with physical therapy, including the provision 
of equipment and advice on ADL tasks, led to a significant improvement in speed 
and ability of completing ADL tasks in a study with 37 patients with ataxia due to 
multiple sclerosis.16 
 Intensive rehabilitation with occupational therapy combined with physical 
therapy was shown to be of benefit in a study of 42 patients with degenerative 
cerebellar ataxia. Occupational therapy focused on ADL tasks, relaxation, 
personal hygiene, but also on balance exercises, coordinative tasks of the 
upper limbs and trunk, and dual motor tasks. Positive effects on functional 
independence, gait, ataxia severity and falls were found, and maintained in more 
than half of the participants after half a year.47
Speech and language therapy
Only two case reports described the use of speech and language therapy, but 
were not included.42, 43 
Conclusions 
Table 2 contains the level of scientific evidence for the various interventions 
and shows the etiological category for which these interventions are applicable. 
We were not able to make more than two conclusions at level 2 of the EBRO 
classification, meaning they were based on at least two independently conducted 
comparative studies, but not randomized, not double-blind controlled, or with 
insufficient power and consistency (table 1).
TABLE 2 Summary of the level of scientific evidence for the various interventions
CONCLUSIONS DIAGNOSIS LEVEL OF 
SCIENTIFIC 
EVIDENCE
Physical therapy
Conventional physical therapy 
It is plausible that physical therapy improves ataxia severity, 
balance, gait, fall frequency and ADL functioning. 15, 46, 47 
Degenerative cerebellar ataxia 2
Limb ataxia seems to be more resistant to physical therapy 
compared to trunk ataxia. 44, 47
Degenerative cerebellar ataxia, 
MS
2
Long-term outcome appears to be influenced by training intensity 
at home. 15, 46
Degenerative cerebellar ataxia 3
There are indications that training effects are less distinct for 
patients whose afferent pathways are affected. 15, 46
Degenerative cerebellar ataxia 3
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CONCLUSIONS DIAGNOSIS LEVEL OF 
SCIENTIFIC 
EVIDENCE
Patients with mild ataxia seem to be more likely to benefit from 
physical therapy combined with occupational therapy than 
patients with more severe ataxia. 47
Degenerative cerebellar ataxia 3
Physical therapy may result in improvement of balance, gait, 
diadochokinesis and EDSS. 44
MS 3
Use of Johnstone Pressure Splints in addition to physical therapy 
does not have further benefit. 44
MS 3
Physical therapy may improve gait. 45 TBI 3
Physical therapy with the use of weighting, together with 
occupational therapy, can result in improvement of functional 
ability, fatigue and physical functioning. 16
MS 3
Treadmill training
Treadmill training might improve gait and balance. 32, 35, 52 TBI 3
Relaxation and biofeedback therapy
EMG biofeedback may help to reduce the amount of inappropriate 
coactivation of muscle groups. 50
MS,  
Degenerative cerebellar ataxia
3
Relaxation and EMG biofeedback might decrease severity of 
ataxic tremor. 38, 39
TBI 3
Computer assisted training
Adaptive robot therapy may improve coordination of the upper 
limbs. 49
MS 3
Supervised sports
Climbing training might help to improve pointing movements of 
limbs, manual dexterity and balance. 51
Perinatal anoxic encephalopathy, 
TBI, stroke, metabolic 
encephalopathy 3
Occupational therapy
The use of occupational therapy may diminish symptoms of 
depression. 48
Degenerative cerebellar ataxia 3
Occupational therapy combined with physical therapy might 
improve functional status. 16
MS 3
Occupational therapy combined with physical therapy might 
improve functional independence and gait and diminish ataxia 
severity and incidence of falls. 47
Degenerative cerebellar ataxia 3
Speech and language therapy
No conclusion could be made due to insufficient data.
MS = multiple sclerosis, TBI= traumatic brain injury, EMG = electromyogram, ADLs = activities of daily functioning.
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Discussion
In a Spanish study of degenerative cerebellar ataxias, the costs for health care 
and society were estimated to be around 24.500 USD per patient per year. The 
study showed that a substantial part of the direct healthcare costs was spent 
on allied health care.54 Apparently, patients with functional impairments due to 
ataxia are often referred to allied health care workers and these referrals have 
become a sort of routine in the management of these patients. While an effect of 
such interventions is anticipated, and already experienced as such by healthcare 
workers and patients alike in daily practice, there is a lack of good quality clinical 
trials of the effects of allied health care in patients with cerebellar ataxia. 
 Of all allied health disciplines, the efficacy of physical therapy has been 
evaluated most. This is in line with other neurologic conditions, such as stroke 
and Parkinson’s disease. Given that balance problems are a hallmark for ataxia, 
it was expected that for these disciplines most evidence would be found. Most 
of the studies identified and graded were case studies, with a moderate to poor 
quality of methodology. Moreover, there was a wide variation in disease entities, 
sample sizes, types of intervention, and outcome measures. The duration of the 
follow-up was usually short and variable. Based on the relatively poor quality of 
the studies that passed our inclusion criteria and that we have thus reviewed 
here, we re-examined the retrospective studies we had excluded. However, this 
provided no further insight, since they dealt with immediate stroke recovery 
(n=2), involved a non-specified intervention (n=1), or included an insufficiently 
characterized patient group (n=1).17-20
 In general, therapy was tailored to the individual, which is in agreement 
with therapeutic principles, but makes it difficult to generalize these treatment 
protocols. We have here lumped the various aetiologies of cerebellar ataxias 
together, but we appreciate that aspects such as comorbid feature, or the 
intrinsic capacity to improve will differ per disease. In most trials no control 
intervention was used, which complicates the interpretation of whether the 
observed improvement was related to the specific intervention, to a more 
generalized and non-specific element of training, to the natural disease course, 
or to a placebo effect such as attention. An interesting finding in one study was 
that only depressive symptoms improved, without further functional benefit of the 
applied occupational therapy.48 For future studies, it might be valuable to examine 
whether the presence of depressive symptoms influences the effectiveness of 
such therapies, or whether possible functional improvements are driven by a 
reduction of depressive symptoms due to the intervention. Similarly, the influence 
of cognitive disturbances, which may co-exist in many diseases that underlie 
ataxia, should be explored. A blinded assessor was rarely used, which may 
have caused bias during effects measurements. Lastly, there may be a possible 
publication bias, as all included studies reported a positive effect.
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So, what are the practical recommendations? Physical therapy and  
occupational therapy are recommended in cerebellar disease, based on two  
level 2 conclusions for physical therapy, and the many level 3 conclusions 
for physical therapy and occupational therapy (table 2). However, because 
of the variety of, often individualized interventions and because most of the 
interventions were not described in full detail, it is impossible at this stage to 
provide a detailed guideline for such a physical therapy program The relatively 
better studies suggest that the program should be intensive and adjusted to 
the needs and limitations of the patient; that patients should be encouraged to 
practice at home; and that treatment should start in earlier stages of disease, 
since those patients seem to be more likely to benefit. Better still is to stimulate 
the medical community to design and conduct randomized and controlled 
trials that explore the effect of allied health care interventions in neurological 
conditions such as cerebellar ataxia. We could learn from the work done in the 
field of Parkinson’s disease.55
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Abstract
Physiotherapy plays an important role in the management of patients with 
degenerative cerebellar ataxias. However, our insight in the quantity and quality 
of physiotherapy prescription in this group of patients is incomplete. The 
purposes of this study were to investigate the utilisation of physiotherapy and 
patient satisfaction in patients with degenerative ataxias in the Netherlands 
and to examine the level of expertise and needs of physiotherapists treating 
ataxia patients. Questionnaires were sent to members of the Dutch association 
for patients with degenerative cerebellar ataxias (n=532). In addition, 181 
questionnaires were sent to the physiotherapists who had recently treated 
the patients who responded. Eventually, 317 questionnaires from patients 
(60%) and 114 questionnaires from physiotherapists (63%) could be used 
for further analysis. Sixty-four percent of the patients were currently treated 
by a physiotherapist. Their median treatment duration was 5 years. 19 percent 
of the patients had never been referred, often despite the presence of 
limitations in daily activities. On the other hand, some participants without 
reported limitations had received physiotherapy. In general, participants 
were satisfied with their physiotherapist. The most reported treatment goals 
were improvement or maintenance of balance, general physical condition, 
and mobility. Physiotherapists reported lack of ataxia-specific expertise and 
expressed the need for education and evidence-based guidelines. Referral 
to and use of physiotherapy in patients with degenerative cerebellar ataxia 
in the Netherlands are currently inconsistent, and not in agreement with 
the little scientific evidence available. Referral rates are high, but referrals 
and actual necessity are discrepant; treatment duration is long; and ataxia-
specific expertise amongst physiotherapists is insufficient. Evidence-based 
recommendations and specific training of physiotherapists are needed.
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Introduction
Cerebellar ataxia is characterized by typical disturbances in walking, 
balance, dexterity, eye movements, and speech. Among the many causes, 
the degenerative diseases form a significant group. These disorders are 
progressive, incurable, and often have major consequences for mobility and 
quality of life.1, 2 International prevalence estimates of degenerative cerebellar 
ataxias vary from 5.2 to 18.5 per 100,000 inhabitants.3-9 
 In a recent Spanish study on the costs for health care and society for 
degenerative cerebellar ataxias, the costs were estimated to be almost 
24.500 USD per patient per year on average.1 The study also showed that a 
large proportion of the direct medical expenses were explained by the use of 
rehabilitative interventions. This seems to be consistent with the fact that there 
are no pharmacological therapies for these disorders, which makes allied health 
care and in particular physiotherapy relevant in the management. However, it 
is currently unclear how many patients are actually referred for treatment and 
how the referred patients are being treated. Presumably, there will be much 
heterogeneity within the physical therapies installed. This is mainly due to the 
unclear scientific state of these interventions and the lack of guidelines in 
this area. The objective of the current study was to gain more insight into the 
utilization of physiotherapy for degenerative ataxias in the Netherlands. We 
examined both the quantity and quality of the physiotherapy, focusing on referral 
rates, treatment duration, expertise of the therapists, and patient satisfaction. 
Methods
Study design
Questionnaires were sent to all 532 members of the Dutch association 
for patients with degenerative cerebellar ataxia in the Netherlands (ADCA-
vereniging, www.ataxie.nl). Patients who had received treatment by a physical 
therapist during the previous 12 months were asked to give permission to 
send a second questionnaire to their physiotherapist. Subsequently, 181 
questionnaires were sent to the patients’ therapists. In addition to the 
postal questionnaires, a link to a digital version of the questionnaire for 
both patients and therapists was provided. The term ‘physiotherapist’ in this 
paper also entails Cesar and Mensendieck exercise therapists, who all deliver 
physiotherapy in The Netherlands. The questionnaires were a modified version 
of those previously used in comparable studies in Parkinson's disease, and 
have been developed by physiotherapists and neurologists.10 Most answer 
options were multiple-choice, but subjects were encouraged to explain certain 
answers and to write additional comments. Both the questionnaires for the 
patients and therapists were analyzed anonymously. Approval for this study 
was obtained from the research ethics committee of the Radboud University 
Nijmegen Medical Centre, CMO Region Arnhem-Nijmegen.
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Patient questionnaire
The questionnaire contained questions to gain inside in diagnosis, disease 
duration, falling, and any problems in mobility and daily functioning. Patients 
were also asked about their use of physiotherapy and whether they were 
satisfied therewith. 
Therapist questionnaire
In this questionnaire, physiotherapists were asked about general professional and 
treatment characteristics, such as working experience and interest in neurological 
disorders and ataxia, as well as about the treatment characteristics of the specific 
patient referred to them, including treatment goals and duration. Therapists were 
asked to rank the three key treatment goals for their patient.
Analysis
Patients were classified first according their mobility in combination with their 
frequency of falls. This was done to evaluate the necessity for referral in 
relation to indications for physiotherapy. Participants who had fallen at least 
twice during the previous year or those who reported to use walking aids or 
were not able to walk, were regarded by us as having a clear indication for 
physiotherapy. Participants with no or mild gait difficulties (no help required), 
who had fallen less than two times during the previous year, were considered to 
have no obvious indication for physiotherapy. 
 Secondly, patients were classified according to the level of problems in 
daily life that they reported to have experienced during the previous month; no 
problems; mild problems; moderate problems (patient has difficulties doing 
simple activities without help); and (very) severe problems (patient is (often) 
dependent from others in daily functioning and mobility). This categorization 
enabled us to use the patient’s perspective regarding the motives and goals for 
physiotherapy treatment. 
 Analysis of the data with the Shapiro-Wilk test showed that the data 
were not normally distributed. To test for differences between the different 
categories, non-parametric tests were used, including the Mann-Whitney and 
Kruskal Wallis tests for numeric data and Chi-square and Fisher exact tests for 
proportions. Significance level was set at <0.05.
Results
Response
Of the 532 patient questionnaires, 359 were returned (68%). Twenty-seven 
were sent back by respondents who were not ataxia patients, but who were 
on the registry because of a financial donation to the patient association. Five 
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questionnaires were returned blank. Of the 208 patients receiving physiotherapy 
in the previous year, 181 gave consent to approach their physiotherapist (87%). 
Completed questionnaires were returned by 116 physiotherapists (64%). Seven 
of the patients were excluded from further analysis, because the diagnosis was 
not known or not confirmed by a neurologist or clinical geneticist. One patient 
was excluded because of paraplegia and two patients because a different 
diagnosis was written on the referral letter to their physiotherapist. Therefore, 
317 patient questionnaires and 114 physiotherapist questionnaires were used 
for final analysis. Baseline data of the patients are shown in table 1.
TABLE 1 Baseline data at the time of the questionnaire 
DIAGNOSIS
ITEM
ALL 
PATIENTS
N=317
100%
SCA
N=255
80.4%
ILOCA
N=12
3.8%
EOCA
N=7
2.2%
MSAC
N=12
3.8%
OTHER 
DIAGNOSIS
N=31
9.8%
Age  
(years, mean ± SD)
59.9 ± 13.5 
(Range 15-89)
59.8 ± 13.1 66.3 ± 11.7 47.7 ± 16.3 68.1 ± 8.9 57.1 ± 16.1
Disease duration  
(years, mean ± SD)
16.2 ± 11.6
(Range 0-68)
15.4 ± 10.3 14.6 ± 14.9 29.4 ± 20.7 9.3 ± 4.8 23.4 ± 14.8
Men (%) 47.8 47.1 75.0 42.9 58.3 38.7
Asymptomatic (%) 2.8 3.5 0 0 0 0
Other diagnoses: autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS), episodic ataxia type 2 (EA2),  
Friedreich’s ataxia, and ataxia with oculomotor apraxia type 2 (A0A2)  
SCA= spinocerebellar ataxia, ILOCA= idiopathic late onset cerebellar ataxia, EOCA= early onset cerebellar ataxia, 
MSAc= multiple system atrophy of the cerebellar type
Referral and consultation
At the time of the questionnaire, 64 percent of the patients used physiotherapy. 
19 percent had never been treated by a physiotherapist. Patients who never 
had been treated, significantly had shorter disease duration, experienced less 
falls, and reported less often and less severe problems with standing, walking, 
changing posture, using hands in daily activities and functioning in the previous 
month (table 2). Most patients were referred to a physiotherapist by their general 
practitioner, neurologist or rehabilitation physician. However, nearly one out of 
ten patients visited a physiotherapist without a referral by a physician. Only 18 
percent of all patients did not have a clear indication for physiotherapy. Still, 
39 percent of this group currently received physiotherapy. On the contrary, 30 
percent of the patients with an indication did not receive physiotherapy (data 
not show). Of those who never received physiotherapy treatment, 53 percent 
indicated that the reason for not being referred was that this had never been 
discussed by their physician. Patient’s unwillingness to visit a physiotherapist 
increased with the severity of the problems experienced in the previous month, 
from 13 percent in patients with mild problems to 57 percent of those with 
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severe problems (data not shown). Reasons reported for unwillingness to visit 
a physiotherapist included ‘no expected benefits of physiotherapy’, ‘doing own 
exercises’, and ‘lack of time. Of all patients who never had been referred, only 
17 percent indicated that they considered physiotherapy as potentially useful, 
whereas 39 percent did not know whether physiotherapy could be useful. 
 One out of three physiotherapists reported a lack of information on the 
referral letter. Missing information included the precise diagnosis (69%), a 
treatment goal (10%), the patient’s functional impairments (9%), and information 
about the disease (5%) (data not shown).
TABLE 2 Patient characteristics, comparing those with versus those without physiotherapy. 
PHYSIO THERAPHY
ITEM
TREATMENT
(CURRENTLY 
OR IN PAST)
(N=255)
NEVER BEEN 
TREATED 
WITH
(N=60) P- VALUE
Standing (%) - No problems 9.4 34.5 <0.001
- Mild problems (no help required) 38.6 37.9
- Moderate problems (some help required) 26.0 17.2
- Severe problems 26.0 10.3
Walking (%) - No problems 3.1 27.6 <0.001
- Mild problems 22.4 41.4
- Walking aid needed 48.0 20.7
- Not able to walk 26.4 10.3
Changing posture (%) - No problems 3.5 20.7 <0.001
- Mild problems 46.9 53.4
- Moderate problems (some help required) 31.9 19.0 
- Severe problems 17.7 6.9 
Using hands with 
daily activities (%)
- No problems 24.4 48.3 0.002
- Mild problems 48.4 38.3
- Moderate problems (some help required) 17.3 8.3 
- Severe problems 9.8 5.0
Fall frequency 
previous year (%)
- No falls 22.1 27.1 0.013
- One fall 14.9 28.8
- More than one fall 63.1 44.1
Functioning previous 
month (%)
- No problems 2.0 25.4 <0.001
- Mild problems 39.3 47.5
- Moderate problems 27.0 15.3
- Severe problems 15.5 6.8 
- Very severe problems 16.3 5.1 
No clear indication 
for physiotherapy (%)
No or mild walking problems and less than 
2 falls.
54.4 45.6 <0.001
Indication for 
physiotherapy (%)
More than 1 fall, or walking with aid. 87.1 12.9 <0.001
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Treatment characteristics
The physiotherapy was mainly provided in the therapist’s clinic (table 3). Of 
all patients who had ever been treated, 19 percent received group treatment. 
Median treatment duration was 60 months (inter-quartile range (IQR) 18 to 96) 
for all patients being currently treated, with a median frequency of 1 session 
(IQR 0.8 to 2) per week. Treatment duration positively correlated with the 
severity of problems patients experienced in daily life within the previous month 
(table 3). The five main goals for treatment were the same for patients as for 
physiotherapists, namely improvement or maintenance of balance; general 
physical condition; improvement of gait; muscle strength; and self confidence 
(table 3). Despite the fact that patients reported falls and disabilities on the 
items ‘stance’, ‘gait’, ‘changing posture’, and ‘using hands in daily activities’, 
these items often were not selected as a treatment goal. 
 Treatment mainly consisted of active exercises for improving gait, balance, 
muscle strength, mobility, and cardiovascular fitness. The majority (88%) of the 
therapists used devices and tools, mainly fitness equipment. Six therapists used 
hydrotherapy. Therapy was evaluated with the use of measurement tools by 67 
percent of the therapists treating patients functioning at higher level, and by 45 
percent of the therapists treating patients functioning at lower level. Tools most 
often used for patients functioning at higher levels were the (Dutch) Patient 
Specific Complaints Test (PSK)11 (39%), the 6-Minute Walk test (37%), and the 
Berg Balance Scale (26%). 29 percent of the therapists used the 10-Meter 
Walking Test, the Berg Balance Scale, and own tests to evaluate treatment of 
patients functioning at lower levels. Only one out of ten used an ataxia-specific 
tool, namely the Scale for the Assessment and Rating of Ataxia (SARA).12
 A third of the therapists reported that the problem targeted by the 
therapy had improved during the treatment period, while 30 percent reported 
deterioration. Comparison of the answers of the physiotherapist with those of the 
patient showed that 18 percent of the therapists reported a more negative effect, 
while 23 percent reported a better result than the patient did. Of the patients 
who had reported improvement, 74 percent experienced an improvement on 
the long term, ranging from months to a still ongoing effect. Statistical analysis 
showed no correlation between treatment frequency and the reported effect. 
Table 3 shows the reported changes in symptoms categorized according to the 
functional problems in the previous month, as indicated by the patient. 
 On the question how much therapy was still needed for their patient, most 
therapists answered ‘chronically’, with therapy on a weekly basis. 
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TABLE 3 Treatment characteristics and categorization according to functioning previous month.
FUNCTIONING PREVIOUS MONTH
ITEM
NO PROBLEMS
(N =20)
MILD 
PROBLEMS
(N =132)
MODERATE 
PROBLEMS 
(N=77)
(VERY) SEVERE 
PROBLEMS 
(N=87) P- VALUE
Physiotherapy treatment ever (%) 25.0 77.7 88.5 92.0 <0.001
Physiotherapy at present (%) 25.0 57.3 69.2 79.1 <0.001
Treatment location (%) n=4 n=101 n=68 n=78
- Therapist’s practice 50 65.5 61.6 37.5 0.001
- Hospital 0 11.0 12.7 0.9 NS
- Nursing home 0 2.0 1.5 21.0 <0.001
- Rehabilitation centre 0 14.4 10.7 9.6 NS
- Patient’s home 0 4.4 12.3 26.5 <0.001
- Other 50 2.8 1.2 4.5 <0.001
Treatment duration 
(months, median, interquartile range) 9 (NA) 36 (12 - 72) 48 (12 - 105) 72 (48 - 132) <0.001
Patient’s goal (%)*
- Balance 100 78.2 72.1 53.2 0.002
- Transfers 0 8.9 13.2 23.4 0.040
- Contractures 0 7.9 20.6 23.4 0.020
Treatment in line with patient’s 
goal (%) 0.001
- No 0 1 8.8 8.0
- Yes 100 84.8 66.2 54.7
- Partially 0 14.1 25.0 37.3
Something lacking in  
treatment (%) 25 10.7 26.0 17.4 0.034
Change of symptoms (%) 0.001
- Deterioration 0 17.7 32.8 45.3
- Stable 25 34.4 37.3 32.0
- Improvement 75 29.2 22.4 10.7
- Not known 0 18.8 7.5 12.0
If improvement, long term 
diminishing of symptoms (%)
100 76 71.4 57.1 NS
Change of physiotherapist after 
dissatisfaction (%)
0 17.2 16.7 18.9 NS
Satisfaction score (0-10, mean ± SD) 7.8 ± 0.5 7.9 ± 1.2 7.2 ± 2.0 7.4 ± 1.9 NS
*  Only significant differences are shown. Other goals were improvement and maintenance of: physical condition, 
self confidence, muscle strength, getting up, stance, walking, walking stairs, reaching, writing, posture, moving 
objects, use of aids, self-reliance and turning while standing, pain reduction, and other goals
NS = non-significant
NA = not applicable
Significance level p<0.05
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Patient satisfaction
Nearly all patients reported that the treatment was partially or totally in accordance with 
their goals. The mean satisfaction score was 7.6 (SD 1.7) on a 1 to 10 scale. Patients 
with subjective improvement gave a significantly better satisfaction score (8.2, SD 1.2) 
than those whose problems did not improve (7.4, SD 1.7) or those who did not know 
whether their symptoms had changed (7.1, SD 2.1). Seventeen percent reported that 
they were missing something in their treatment. Five percent of the patients missed 
specific knowledge or specific treatment by their physiotherapist concerning their 
disease. A change of therapist due to dissatisfaction was made by 17 percent of all 
patients ever being treated by a physiotherapist. The main reasons for switching were 
the same as the missing items reported above. Two percent of the patients switched 
because they were hoping to achieve more with the guidance of another therapist. 
Professional expertise
95.6 percent of the responding therapists were physiotherapists, the remaining 
4.4 percent were Cesar and Mensendieck exercise therapists. Median working 
experience of the physiotherapists was 13 years (IQR 5 to 24.3). Of all therapists, 
81 percent were interested in ataxia, but only 11 percent of all therapists 
considered themselves as having expertise in treating patients with ataxia. 
Training in neurology, which could be a post-graduate program or a course, had 
been attended by 36 percent, but only 2 percent had been trained in ataxia. The 
median number of ataxia patients treated by each therapist during the previous 
year was 2 (IQR 1 to 3), varying from 1 to 20. Therapists estimated the median 
needed number of patients to treat to become an ataxia expert 10 (IQR 6 to 20). 
On the question who should treat patients with ataxia, half of the physiotherapists 
answered ‘all therapists’, while the other half answered ‘specialized therapists’. 
Two-third of the physiotherapists reported a need for guidelines for treatment of 
patients with ataxia. Also information about the disease (49%), education (39%), 
and consultation with the referrer (23%) were desired. 
Discussion
This study demonstrates high physiotherapy referral rates in patients with 
degenerative cerebellar ataxia and generally long treatment duration in The 
Netherlands. This is comparable to studies in patients with Parkinson’s 
disease (PD).10, 13 There might be an inclusion bias, since the patients were 
members of an association for patients with degenerative cerebellar ataxia in 
the Netherlands, and perhaps more motivated to be referred and to be trained 
by a physiotherapist. Despite that, this study shows that patients with relevant 
functional problems often do not use physiotherapy (30%). This could be 
important, since there is no known pharmacological treatment and patients may 
benefit from balance training and from learning compensatory strategies.14, 15
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In the Netherlands, neurologists are responsible for most of referrals to 
physiotherapists in PD patients.10 In our survey, general practitioners and 
rehabilitation physicians were responsible for as many referrals as the 
neurologists. More than half of the patients who had never been referred 
reported that physiotherapy had not been discussed by their physician. It is 
possible that physicians are insufficiently aware of the possible benefit of 
physiotherapy or there might be a lack of time to screen for relevant indications. 
There was also a group of patients who declined referral to a physiotherapist. 
Surprisingly, the proportion not wanting to be referred was relatively larger 
when patients experienced more disabilities, up to 57 percent. This might 
be due to mobility problems or a fear to go outside, refraining patients from 
travelling to a physiotherapist. However, it could also be the case that patients 
and caregivers are not aware of the possible benefits of physiotherapy even 
in the later stages. On the other hand, 25 percent of the patients who did not 
experience any problems in their functioning in the previous month, and 57 
percent of the patients with mild functional problems were currently receiving 
physiotherapy (table 3). It might be that these patients expect too much in terms 
of improvement or prevention of further decline. Patients who did not experience 
improvement of problems were less satisfied (table 3). 
 Importantly, despite the specific functional impairments patients had 
reported on several domains, these items often were not selected as a goal 
for treatment. The focus of treatment goals patients had selected shifted from 
‘balance’ in patients with no or mild functional problems to ‘transfers’ and 
‘prevention and treatment of contractures’ in more advanced disease stages 
(table 3). Furthermore, the physiotherapists chose more training goals than their 
patients, but did include the goals selected by the patient. Taking these findings 
into account, better pre-treatment discussions between patient and therapist 
may lead to a more targeted and relevant way of training and an improvement of 
patient satisfaction. 
 Both patients and physiotherapists reported lack of knowledge and expertise 
of the therapists regarding treatment of patients with cerebellar ataxia. This 
is probably the consequence of the relatively low incidence of patients with 
degenerative cerebellar ataxia and lack of scientific evidence for physiotherapy 
in this group of patients.15 Consequently, educational programs are rare. 
Physiotherapists reported to have been treating a median of 2 patients with 
ataxia in the previous year. Physiotherapists used measurement instruments 
not designed for patients with ataxia to evaluate the training effect. Moreover, 
physiotherapists and patients should be aware that ataxia is often progressive. 
Focusing on improvement only might therefore be counterproductive and 
demotivating. Physiotherapists indicated a need for education and evidence-
based guidelines and often missed some information about diagnosis and 
treatment restrictions at referral. 
 Despite the inconsistency between actual treatment and treatment goals 
reported by the patient, and the fact that patients missed ataxia-specific 
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expertise of their therapist, the patient-physiotherapist relationship in general 
seemed to be good. Most patients were satisfied with their therapists, and 50 
percent reported the same effect of the treatment as their therapist.
 Several physiotherapists reported that it might be useful to refer a patient to 
a specialized physiotherapist or specialized allied health care team first in order 
to come to a suitable treatment plan, taken over by general physiotherapists or 
other allied health care therapists. Furthermore, the majority of the therapists 
reported that chronic treatment on a weekly basis is needed for their patients. 
This is in contrast to what is starting to emerge from recent studies. It might 
be more effective to start an intensive, high frequency training program first, 
followed by chronic, less intensive and low-frequency training at home or at the 
physiotherapist’s practice. Such a program has been shown effective in patients 
with degenerative cerebellar ataxias.14, 16 Both short-term intensive and more 
long-term training regimes have been shown to be safe, feasible and effective 
in other neurological disorders, but more research addressing the best training 
protocols is warranted.17-19
 In the Netherlands, community care for patients with PD has been 
implemented first by developing evidence-based guidelines, followed by training 
of a selected number of health professionals who are collaborating in community 
networks, and lastly by referral of patients to these trained therapists.20 This 
improved organization of care makes it easier for both patients and physicians 
to select the most appropriate therapist to refer to, improves quality of care, 
and reduces societal costs.21 This could be the blueprint for patients with other 
movement disorders such as ataxia. Future research, in particular randomized 
clinical trials of physiotherapy in patients with degenerative ataxia, is necessary 
to develop evidence-based guidelines. 
Conclusions
Referral to and use of physiotherapy in patients with degenerative cerebellar 
ataxia is currently inconsistent, and not in line with the sparse literature available. 
In the Netherlands, referral rates are high and referrals are insufficiently targeted. 
Moreover, treatment volumes per physiotherapist are low, physiotherapists have 
insufficient ataxia-specific expertise, and treatment duration is long. To improve 
care for this group of patients, the development of evidence-based physiotherapy 
guidelines for ataxia and community care networks of specifically trained 
physiotherapists is advised.
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Gait adaptability training improves 
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Abstract 
Balance and gait problems in patients with cerebellar degeneration lead to 
reduced mobility, loss of independence, and frequent falls. It is currently 
unclear, however, whether balance and gait capacities can be improved 
by training in this group of patients. Therefore, the aim of this study was 
to examine the effects of gait adaptability training on obstacle avoidance 
and dynamic stability during adaptive gait. Ten patients with degenerative 
cerebellar ataxia received 10 protocolized gait adaptability training sessions of 
1 hour each during 5 weeks. Training was performed on a treadmill with visual 
stepping targets and obstacles projected on the belt’s surface. As the primary 
outcome, we used an obstacle avoidance task while walking on a treadmill. We 
determined avoidance success rates, as well as dynamic stability during the 
avoidance manoeuvre. Clinical ratings included the Scale for the Assessment 
of Ataxia (SARA), 10 meter walking test, Timed Up-and-Go Test, Berg Balance 
Scale, and the obstacle subtask of the Emory Functional Ambulation Profile 
(EFAP). Following the intervention, success rates on the obstacle avoidance 
task had significantly improved compared to pre-intervention. For successful 
avoidance, participants allowed themselves smaller stability margins in the 
sagittal plane in the (shortened) pre-crossing step. However, in the subsequent 
steps they returned to baseline stability values more effectively than before 
training. SARA scores and the EFAP obstacle subtask improved significantly as 
well. This pilot study provides preliminary evidence of a beneficial effect of gait 
adaptability training on obstacle avoidance capacity and dynamic stability in 
patients with cerebellar degeneration. 
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Introduction
Degenerative cerebellar ataxias are characterized by progressive disturbances in 
coordination, balance, and gait. Patients show an increased postural sway during 
stance and walking, which is omnidirectional, but greatest in anterior-posterior 
direction.1, 2 Safe ambulation requires the ability to make gait adjustments 
dependent on environmental demands, such as stepping over uneven tiles. 
These step adjustments require a longer single leg stance phase. During 
avoidance of obstacles however, lateral instability is reported to be higher in 
ataxia patients due to a longer single-leg phase and simultaneous counter phase 
trunk movements, which are essential for obstacle crossing.2, 3 All these factors 
contribute to a high risk of falling, with an incidence of falls up to 93% per year 
in patients with cerebellar degeneration, often accompanied with injuries and 
limitations in activities of daily living.4
 There are no pharmacologic treatments available at this moment that can 
provide sufficient symptomatic relief. As a result, physiotherapeutic interventions 
play an important role in the management of degenerative cerebellar ataxias, with 
improvements of balance, physical condition, and gait as main training goals.5 
As the cerebellum functions as a primary site for adaptation of limb movements 
and dynamic regulation of balance, and cerebellar patients are also known to 
have deficits in motor learning6-8, the potential effectiveness of balance and gait 
training can be questioned. However, there is evidence of adaptation, functional 
motor retraining, and motor learning after cerebellar damage.9-11 In addition, other 
studies suggest potential beneficial effects of physiotherapeutic interventions on 
balance, gait, upper limb functioning, and ataxia severity.5
 Since adjustment of gait patterns to the variable requirements of the 
environment is essential in daily life, gait adaptability training might be useful in 
improving walking and avoiding falls. This training modality has been reported to 
improve obstacle avoidance abilities and to reduce fall rates in healthy elderly. 
It was also found to ameliorate walking speed, step adjustments and balance in 
patients with stroke.12-15 The aim of this study was to examine the effects of gait 
adaptability training on an instrumented treadmill with visual cues on obstacle 
avoidance and dynamic stability in patients with degenerative cerebellar ataxia. We 
hypothesized that training would improve the participants’ ability to avoid sudden 
(physical) obstacles during walking on a treadmill, as well as dynamic stability during 
the obstacle crossing steps. We also expected these improvements to translate to 
better performance on a clinical overground walking test involving obstacle avoidance.
Methods
Subjects
We recruited ten male patients (age 61.4 ± 5.7 years, disease duration 8.5 
± 7.3 years) from the Department of Neurology of the Radboud University 
Nijmegen Medical Centre, seven diagnosed with Sporadic Adult-Onset Ataxia 
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(SAOA), two patients with spinocerebellar ataxia type 6 (SCA6), and one with 
spinocerebellar ataxia type 3 (SCA3). Patients were included if they were 
diagnosed with degenerative cerebellar ataxia and no other causes for their 
symptoms were found. Exclusion criteria were the use of walking aids, presence 
of visual impairments, other disorders influencing walking, interfering cognitive 
impairments, and the use of medication which may influence balance, walking 
or cognition. Inclusion and exclusion criteria were re-checked during an intake 
visit by means of a standardized medical history and neurological examination. 
At this intake visit, participants also completed a familiarization session with the 
obstacle avoidance task.
 Participants did not receive other training aimed at improvement of balance 
or gait during the study period. All participants gave written informed consent and 
approval was obtained from the local medical ethics committee. 
Intervention
The participants received ten protocolised training sessions of one hour each 
over a period of five weeks, which were supervised by the same physical therapist 
(JDB). Training was performed on a treadmill instrumented to project visual 
cues on the belt, such as obstacles and stepping targets (C-mill, Forcelink BV, 
Culemborg, The Netherlands)16 (figure 1). The embedded force platform provided 
detection and feedback of several gait parameters, which were also used to 
adjust the timing of visual context to participant’s gait.17 Each training session 
consisted of 6 blocks of gait adaptability exercises (see appendix I). During 
training, participants walked at a comfortable speed (as assessed in training 
sessions 1, 2, and 6), without using the handrails. The level of difficulty was 
adapted to the participant’s abilities and was gradually increased to keep the 
training challenging. 
FIGURE 1 The C-mill 
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Pre- and post-intervention measurements
To evaluate the effects of training, the outcome measures were assessed a  
week before the first training (pre-intervention) and one week after the last 
training (post-intervention). Participants performed a standardized instrumented 
obstacle avoidance task while walking on a treadmill 12, and several clinical tests 
were done (see below). 
 The obstacle avoidance task involved 30 obstacles (during two series of 15 
trials), while walking on a treadmill (width 1.25m [w]) at a fixed velocity of 2 or 
3 km/hr, depending on the participant’s abilities. A wooden obstacle (40 cm [l] 
× 30 cm [w] × 1.5 cm [h]) was held by an electromagnet, just above the walking 
surface in front of the non-dominant foot at a distance of approximately 10 cm 
from the most anterior position reached by the toes. Reflective markers attached 
to the feet, legs and trunk were recorded by a 6-camera 3D motion analysis 
system (Vicon, Oxford Metrics, London, UK) and were processed in real time. 
Based on the timing of heel strikes, a computer program (Matlab, version 2011a, 
The Math Works Inc., Natick) triggered the obstacle to be released at different, 
pre-set moments in the step cycle, which were unpredictable for the participants. 
Contact with the obstacle, stepping to the side, or holding on to the safety 
bar were defined as a failure to avoid the obstacle. Participants wore a safety 
harness attached to the ceiling, and their own comfortable low-heeled shoes. 
 The clinical tests used were the Scale for the Assessment of Ataxia 
(SARA)18, the 10 meter walking test (10MWT, comfortable and fast speed)19,  
the Timed Up-and-Go Test (TUG)20, the Berg Balance Scale (BBS)21, and the 
obstacle subtask of the Emory Functional Ambulation Profile (EFAP)22. To assess  
participants’ level of confidence in balance, we used the short version of the 
Activities Specific Balance Scale (ABC).23 Participants had to indicate on a 
questionnaire whether they had experienced falls in the six weeks prior to the 
pre-intervention and prior to the post-intervention measurements. Another purpose 
designed questionnaire was used to evaluate their experiences with the training.
Data analysis
Obstacle avoidance scores were noted during the experiment and verified post 
hoc based on video recordings and 3D marker data. To determine the difficulty 
level, for each trial the available response time (ART) was calculated, defined as 
the time span between the instant of obstacle release, and the moment when 
the toes would have passed the front of the obstacle if no alteration of the stride 
had been made. The ART was calculated by extrapolating the walking pattern 
of the previous steps. Trials in which the ART was too short (<0.15 s; virtually 
impossible to succeed), or too long (>0.75s; hardly any gait adjustment required), 
were excluded from further analysis.24 Obstacle avoidance success rates were 
calculated as the percentage of successful trials of the included trials. Step width 
and centre of mass excursions (CoM) were extracted from the 3D-marker data. 
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Step width was defined as the distance between the malleolus markers of each 
foot, corrected for the marker diameter. In addition, the extrapolated centre of 
mass (XCoM) was calculated, which corrects the centre of mass for its velocity 
[25]. The margin of stability (MoS) was defined as the distance between the 
XCoM and the edge of the base of support at foot contact.25 The MoS was used 
as a measure for dynamic stability. As a measure of body sway, the peak-to-peak 
excursions of the XCoM in mediolateral direction were calculated.
 Obstacle avoidance can be accomplished in two ways: 1) by a long step 
strategy, in which the step is lengthened to cross the obstacle in one go, or 2) by 
a short step strategy, where the step in front of the obstacle is shortened before 
crossing it with the ipsilateral foot. Both strategies were analysed separately 
regarding dynamic stability. Dynamic stability25 was assessed in the anterior-
posterior and lateral direction for the two steps prior to obstacle presentation 
(control steps), the shortened step in front of the obstacle (short step strategy), 
the steps during obstacle crossing, and the three (short step strategy) or five 
(long step strategy) subsequent steps. The patient specific reference MoS was 
determined as the average MoS of the two control steps in all trials, minus twice 
the standard deviation. The percentage of steps within these reference values 
was determined. 
Statistical analysis 
Outcome measures were compared between pre- and post-intervention using the 
Paired Sample T-Test or the Wilcoxon Signed-Rank Test, depending on whether 
the data were normally distributed or not (Shapiro-Wilk test). Dynamic stability 
was analysed using repeated measures ANOVA with step and measurement time 
(pre- or post-intervention) as within subject factors, with post hoc Paired Sample 
T-Tests. Significance level was set at p < 0.05, with adjusted p values (p<0.01) 
for post-hoc tests to account for multiple testing. 
Results
All patients completed the training and no adverse advents occurred. 
Obstacle avoidance task and dynamic stability
The level of difficulty of the obstacle avoidance task, as expressed by the average 
ART, did not differ between pre- and post-intervention (0.469 s vs. 0.473 s 
respectively, p=0.348). Average success rates on the obstacle avoidance task 
on the treadmill significantly increased from 78.5 % before training to 94.8 % 
after training (table 1). Participants most frequently used a short step strategy 
to cross obstacles, and the preference for this strategy further increased after 
training (76.7 vs. 63.0% before training, p=0.003). 
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 In this task, dynamic stability in the anterior-posterior direction differed 
between steps (F7,63=29.904, p<0.001). The shortened step in front of the 
obstacle resulted in reduced dynamic stability compared to the control steps (25.6 
vs 98.8% of MoS within reference values, p<0.001). The deviation of MoS values 
from reference did not fully restore in the subsequent 5 steps (all p values <0.01). 
 The effects of training on dynamic stability also differed between steps (time 
x step; F7,63=4.813, p<0.001). Following the intervention, in the shortened 
pre-crossing step the participants tended to allow even greater deviation from 
their reference dynamic stability values in order to successfully avoid the 
obstacle (8.9% post-intervention vs 25.6% pre-intervention, p=0.087). However, 
they more effectively restored their MoS to reference values in the subsequent 
steps (figure 2.a), which already began in the crossing phase (from 24.2% to 
60.4% of MoS values within reference values, p=0.004). Dynamic stability in 
the lateral direction was less affected by the obstacle, and did not demonstrate 
effects due to training (F7,63=1.262, p=0.284) (figure 2.b). No significant 
changes were observed in dynamic stability during the long step strategy, but 
it must be mentioned that only 7 participants performed this strategy at both 
measurements and in a very limited number of trials. The maximum step width 
and peak-to-peak sway did not change after training.
TABLE 1 Results of the obstacle avoidance task and clinical tests
ITEM
PRE-INTERVENTION
MEAN ± SD
POST-INTERVENTION 
MEAN ± SD P- VALUE
Success rate OAT (% of trials) 78.5 ± 16.8 94.8 ± 5.4 0.019
SARA (pts) 8.7 ± 2.8 8.3 ± 2.8 0.011
BBS (pts) 50.9 ± 4.2 51.2 ± 4.3 NS
TUG (s) 9.8 ± 1.7 9.6 ± 0.8 NS
10MWT comfortable speed (s) 8.1 ± 0.9 7.8 ± 0.8 NS
10MWT fast (s) 6.4 ± 0.6 6.3 ± 0.8 NS
EFAP – obstacle subtask (s) 12.8 ± 1.4 11.8 ± 0.9 0.004
ABC (%) 45.5 47.7 NS
Falls (n) 0.8 ± 1.0 0.4 ± 0.7 NS
NS = non-significant
OAT = obstacle avoidance task on treadmill
SARA = Scale for the Assessment of Ataxia
BBS = Berg Balance Scale 
TUG = Timed Up-and-Go Test 
10MWT = 10 meter walking test
EFAP = Emory Functional Ambulation Profile, obstacle subtask 
ABC = 6-item Activities-specific Balance Confidence scale
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Clinical tests and questionnaires
The results of the clinical balance and gait tests are summarized in table 1. After 
the intervention, the SARA scores and the EFAP-obstacle subtask score had 
improved. No significant improvements in the other clinical tests were found (table 
1). The average SARA total score decreased from 8.7 to 8.3 (table 1). No significant 
differences for each subtask of the SARA score were found, but the heel-shin slide 
subtask improved most frequently (in four patients). The average time to complete 
the EFAP-obstacle subtask had decreased from 12.8 to 11.8 seconds.
 Although participants appreciated the training and reported to feel more 
confident in daily life during evaluation, no significant changes in balance 
confidence (ABC) were found. Fewer falls were reported after the intervention,  
but this was not statistically significant.
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FIGURE 2.A Percentage of steps (±SD) in which the anterior-posterior margin of stability was 
within reference values. Values represent averages of all the participants (n = 10) for each step 
for the short step strategy. The dashed horizontal line indicates the obstacle crossing steps.
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Discussion
In this pilot study, we investigated the effect of gait adaptability training 
on obstacle avoidance and dynamic stability in patients with degenerative 
cerebellar ataxia. The training appeared to be feasible and was well appreciated 
by participants. After training, success rates on the obstacle avoidance task 
improved by 16 %. Patients more frequently used a short step strategy to cross 
obstacles. In order to shorten the step in front of the obstacle, participants 
reduced their dynamic stability in the sagittal plane. Post-intervention they tended 
to allow even greater reduction in dynamic stability in the shortened pre-crossing 
step. This presumably enabled them to avoid foot contact with the obstacle, 
as reflected in the higher success rates. However, their anterior-posterior MoS 
more effectively restored to their individual reference values in the subsequent 
steps. The maximum step width, peak-to-peak sway and mediolateral MoS did 
not change significantly, which implicates that the gain in dynamic stability in the 
sagittal plane did not come at the cost of increased lateral instability.
 The increased use of the short step strategy to avoid the obstacle could 
not be explained by differences in task difficulty, since the available response 
time did not differ between pre- and post-intervention. This is in contrast with a 
study evaluating a similar training program in healthy elderly, in which a long step 
strategy was strongly preferred and this preference did not change over time.26 
It may be that, despite the relatively small sagittal-plane MoS during the  pre-
crossing step, the short step strategy is a safer strategy for obstacle avoidance 
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FIGURE 2.B Percentage of steps (±SD) in which the mediolateral margin of stability was 
within reference values.
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in patients with cerebellar ataxia as it requires a shorter time of single leg 
support compared to the long step strategy.
 During overground walking beneficial effects of training were found on the 
obstacle subtask of the EFAP. Furthermore, we found improvements on the SARA 
total score after training. Although the SARA together with the International 
Cooperative Ataxia Rating Scale (ICARS) are the best studied ataxia scales, no 
study tried to define the Minimal Clinical Difference (MDC) or Minimal Clinically 
Important Differences (MCID) values of the SARA yet. Consequently, it is not 
clear to which extent a change of 0.4 points on the SARA is clinically meaningful. 
However, the mean annual change on the SARA is 1.38 points progression each 
year in patients with spinocerebellar ataxia, implying that without any training,  
no change or worsening of SARA scores was expected in the participants.18
 These results demonstrate that gait adaptability training may lead to better 
whole-body coordination and not just improvement of lower limb ataxia alone.  
No improvement on the Berg Balance Scale was found, which might be due to  
the fact that this test contains many items in which the patients have to stand 
with a small base of support. 
 Studies in other neurological conditions imply that improvements in 
obstacle avoidance may also have clinically meaningful implications for daily 
life situations.27 Furthermore, participants reported to experience more 
confidence in daily life situations and reported fewer falls, albeit not statistically 
significant due to the small sample size. The present findings suggest that C-Mill 
gait adaptability training has strong potential for improving safe community 
ambulation in patients with cerebellar ataxias. 
 This pilot study has some limitations. First, the study group was small and 
there was no control intervention. The latter is relevant, as one would like to test 
the hypothesis that, in ataxia patients, targeted training is more effective and 
tends to generalize more to daily practise than non-specific training. Furthermore 
participants may show improvement on the obstacle task without training, due to 
learning effects. However, possible learning effects were minimized by including 
a familiarization session in the week prior to the pretest. In addition, in a study 
evaluating the effects of an overground gait adaptability training program in 
community-dwelling elderly people, much smaller improvements were observed in 
the inactive control group (6%), compared to the 16% improvement in obstacle-
avoidance success rates observed in the present study.26
 Second, the question remains whether the results persist in the long-term 
and how they translate to activities of daily life and fall risk. Recent studies 
show a long-term effect of an intensive, high frequency training program, 
followed by chronic, less intensive and low-frequency training at home or at 
the physiotherapist’s practice.28, 29 Since long-term outcome appears to be 
influenced by training intensity at home, it may be that additional home exercises 
or continued challenging activities could enhance sustainment of the training-
induced improvement.29
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 Generalization of the present findings to the group of patients with 
cerebellar ataxia at large may be limited, as our participants were able to walk 
independently and patients with mild ataxia seem to benefit more from training 
compared to patients with more severe ataxia.28 Furthermore, this type and 
intensity of training program is less feasible for patients who are not able to 
walk or travel without assistance, which applies to half of the patients with 
spinocerebellar ataxia.4
 In conclusion, this pilot study provides preliminary evidence of a beneficial 
effect of gait adaptability training on obstacle avoidance capacity and dynamic 
stability in patients with degenerative cerebellar ataxia. Therefore this study 
supports the recent findings that physiotherapeutic interventions in patients with 
cerebellar damage can be effective. Future studies should preferably include 
more patients and control interventions, with longer follow-up times to evaluate 
the sustainability of improvements, and also focus on the actual benefits of 
training on activities of daily life and fall frequency. 
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Cerebellar ataxia is characterized by disturbed coordination of movements, and 
manifests as gait and balance problems, falls, loss of dexterity, tremor and 
speech difficulties. There are many diseases that cause ataxia, but an important 
group is formed by the degenerative cerebellar ataxias. These disorders are 
progressive and untreatable, and often lead to a debilitating decrease in mobility, 
loss of independency and reduced quality of life. In daily practice, allied health 
care - and in particular physiotherapy - has an important role in the management 
of patients with degenerative ataxias. 
 The main goals of this thesis were: 1) to analyze the frequency, details 
and consequences of falls (which is one of the major targets for physiotherapy) 
in patients with dominantly inherited degenerative ataxias, 2) to evaluate the 
scientific evidence for allied health care interventions in cerebellar ataxia,  
3) to examine the use and patient satisfaction of physiotherapy in patients with 
degenerative ataxias in the Netherlands, and to assess the level of expertise 
and needs of the physiotherapists who treat these patients, and 4) to explore 
the effect of gait adaptability training in patients with degenerative ataxia. This 
chapter summarizes and discusses the main findings of this thesis, together with 
some ideas and recommendations for future research and treatment.
Falls in cerebellar ataxias
Falls have been extensively studied in ‘healthy’ elderly and in patients with 
stroke, Parkinson’s disease and neuromuscular diseases.1-4 However, little was 
thus far known about falls in patients with degenerative ataxia.
Chapters 3.1 and 3.2 contain the results of the EuroSCA fall study, in which 228 
patients with SCA1, SCA2, SCA3 or SCA6 completed a fall questionnaire about 
falls in the previous 12 months. 113 patients completed a falls dairy and filled 
in extra questionnaires about the first three falls between their annual visits to 
their neurologist. 73.6 percent of patients in the retrospective group and 81.4 
percent of patients in the prospective group reported at least one fall in this period. 
Furthermore, the results showed that falls often had major consequences for these 
patients, including injuries and avoidance of activities due to a fear of falling. Factors 
that were associated with a higher fall frequency in the retrospective study included 
disease duration, severity of ataxia, the presence of pyramidal symptoms, the total 
number of non-ataxia symptoms, and the genotype SCA3. Factors associated with a 
lower fall frequency were the presence of extrapyramidal symptoms (more specifically 
dystonia of the lower limbs) and the genotype SCA2. The total number of non-ataxia 
symptoms and longer disease duration were independently associated with a higher 
fall frequency in a logistic regression analysis, while the presence of extrapyramidal 
symptoms was independently associated with a lower fall frequency. Falls also 
occurred in early stages of the disease. The prospective study confirmed that the 
presence of non-ataxia symptoms was associated with a higher fall frequency. 
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These results imply that neurologists and physiatrists should pay attention to 
falls and near-falls in the management of patients with degenerative ataxia. Fall 
prevention may include: stimulating the use of walking aids, raising awareness 
for the contributing factors, and reducing domestic hazards, for example 
by removing carpeting and providing hand grips. Training might be aimed at 
diminishing the fear of falling, learning how to attenuate the mechanical impact of 
the fall itself, to practice daily routines (including learning patients to make safe 
transfers), and to improve gait and balance. While most patients are referred to 
a physiotherapist for the fall training program, this has not been formally studied 
in great detail, and evidence-based training programs and guidelines are lacking. 
There is scientific evidence that exercise and individually tailored multifaceted 
intervention programs reduce falls in community dwelling older5, and there are 
some indications that physiotherapy may reduce fall frequency in patients with 
multiple sclerosis.6 In contrast, only fully supervised training seems to reduce 
fall frequency in patients with Parkinson’s disease7, and so far no effect of 
tailored multifaceted fall prevention programs in patients with stroke has been 
found.8 Therefore, more research to assesses the effects of fall training and fall 
prevention in patients with cerebellar ataxia is warranted. 
 Our work showed that non-ataxia symptoms, especially the pyramidal 
symptoms, contribute to a higher fall frequency. Therefore, neurologists and 
physiatrists should take these symptoms into account when treating patients with 
cerebellar ataxia. However, it is currently unclear if the treatment of concomitant 
spasticity, with for example botulinum toxin injections, eventually leads to better 
balance and reduction of fall frequency. Furthermore, it would be interesting to 
see whether training aimed at contributing non-ataxia symptoms would result in  
a better clinical results.
 When measuring any effect of future fall prevention programs, the question 
is what method to use for evaluating the frequency of falls. When comparing the 
prospective data with those of the retrospective study at the individual level, 
which was possible for 107 participants, differences in fall frequencies were 
found. More patients reported at least one fall in the fall diary (84.1 vs. 73.6 
percent), but the overall fall frequency was lower. Also, in the prospective study, 
a lower frequency of near-falls was documented and a smaller proportion of 
the patients reported injuries in the fall diary. This might indicate that patients 
overestimate the frequency of falls and injuries retrospectively, or underreport 
(near-) falls and injuries in the fall diaries. Although these differences do not 
affect the main conclusions of the two fall studies, they do lead to questions 
with regard to the validity and applicability of the instruments used to measure 
falls. The use of an automated fall telephone system could be a more preferable 
method for this purpose9, or the use of an online registration program or even 
an application on a smartphone or wearable device could be considered in the 
future10, 11, as most patients will become accustomed to these devices.
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Physiotherapy and training in ataxia
There is a general perception that patients with cerebellar ataxia are commonly 
referred for allied health care interventions, but data on how many patients were 
actually referred to and treated by a physiotherapist, and which methods were 
used were lacking. Furthermore, because guidelines for ataxia treatment are 
unavailable, it was imaginable that there is heterogeneity among the treatments 
provided. The lack of allied health care guidelines for ataxia is largely due to the 
unclear status of the scientific evidence that actually supports the instalment of 
such interventions. Work in the field of Parkinson’s disease has demonstrated 
how important it is to assess current clinical practice in regards to allied 
health interventions,12, 13 as this may serve for development of clinical practice 
guidelines,14 inform the design of randomized clinical trials15, 16 and help to 
optimize professional expertise.17
 
Chapter 4.1 describes the results of a systematic search for clinical trials 
concerning allied health care interventions in cerebellar ataxias.14 trials were 
included, of which even the 4 best studies were formally only of moderate 
methodological quality. There was a wide variation in disorders included, sample 
sizes, types of intervention, and outcome measures. Most trials did not include 
a control intervention or control group. Overall, the studies indicate that physical 
therapy may lead to an improvement of ataxia symptoms and daily life functioning 
in patients with degenerative cerebellar ataxia, or with other diseases causing 
cerebellar ataxia. When added to physiotherapy, occupational therapy may improve 
global functional status, and occupational therapy alone might diminish symptoms 
of depression. There were insufficient data on speech and language therapy. So, 
although there is some evidence to apply physiotherapy and occupational therapy, 
properly designed and sufficiently large trials are needed and the results hereof 
will help to develop recommendations and guidelines for clinical practice. 
Most studies included in the systematic review evaluated the effect of 
physiotherapy. In the majority of the studies, therapy was tailored to the individual, 
which is in accordance with therapeutic principles but this makes it difficult to 
generalize such interventions. Furthermore, often no control intervention was 
used, which complicates the interpretation of whether the observed improvement 
was related to the specific intervention, or to a more generalized and non-specific 
element of training. Physical therapy and occupational therapy are recommended 
for patients with cerebellar ataxia, based on two level 2 conclusions for physical 
therapy, and many level 3 conclusions for physical therapy and occupational 
therapy, based on the EBRO classification.18 The relatively better studies suggest 
that physical training should be intensive, short, and adjusted to the needs and 
limitations of the patient, and that during and after such a program, patients 
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should be encouraged to practice at home. The extent to which the participants 
practised at home was related to the effect that was found, especially on the long 
term. These studies also suggested that treatment should start in earlier stages 
of disease, because those patients are more likely to benefit. Furthermore, since 
patients with degenerative cerebellar ataxia experience falls in early stages of the 
disease, physicians should be aware that training in patients with relatively mild 
symptoms may already be beneficial.
 The studies available do allow the design of a potentially effective, feasible 
training program that should be tested in a randomized controlled study. If proven 
effective, such a program would serve as the basis for a practical guideline that 
can be implemented. 
 Another interesting finding was the positive effect of occupational therapy 
on depressive symptoms. It is known that patients with cerebellar pathology 
can have depressive symptoms.19 as part of the so-called cerebellar cognitive 
affective syndrome (CCAS). CCAS is characterised by impairment of executive 
function, visuo-spatial processing, linguistic function and affective regulations, 
leading to problems with organizing activities, learning difficulties, communication 
problems and personality change.20 Since psycho-active medication can worsen 
neurological symptoms due to side effects, including a markedly increase of 
the risk of falls2, 21, it might be meaningful to examine to what extent allied 
health care therapies impact on CCAS features such as depressive symptoms. 
Furthermore, it could be interesting to assess whether the presence of 
depressive symptoms and cognitive deficits influence the effectiveness of such 
therapies, or whether possible functional improvements are driven primarily by a 
reduction of these non-motor symptoms.22 
Chapter 4.2 describes the results of a study that evaluated utilisation, patient 
satisfaction and professional expertise of physiotherapy in degenerative 
cerebellar ataxias in the Netherlands. Questionnaires were sent to patients with 
degenerative cerebellar ataxias and, subsequently, questionnaires were sent 
to their physiotherapists. Eventually, 317 questionnaires from patients and 114 
questionnaires from physiotherapists could be used for further assessment.  
64 percent of the patients were currently treated by a physiotherapist. Their 
median treatment duration was 5 years. 19 percent of the patients had never 
been referred, often despite the presence of limitations in daily activities. On 
the other hand, some participants without reported limitations had received 
physiotherapy. Nearly one out of ten patients visited a physiotherapist without 
a referral by a physician. Patients’ unwillingness to visit a physiotherapist 
increased with the severity of the problems experienced in the previous month, 
with reasons including ‘not expecting benefits’, ‘doing own exercises’ and ‘lack 
of time’. The most commonly reported treatment goals were improvement 
or maintenance of balance, general physical condition, and mobility. The 
improvement experienced by patients ranged from 10.7 percent of patients 
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with (very) severe problems to 75 percent of the patient with no problems in 
functioning in the previous month. A third of the therapists reported improvement. 
In general, participants were satisfied with their physiotherapist, but patients who 
did not experience improvement of problems were less satisfied. Physiotherapists 
reported to have been treating a median of 2 patients with ataxia in the previous 
year, and they reported lack of ataxia-specific expertise and expressed the need 
for education and evidence-based guidelines. 
This study shows that referral to and use of physiotherapy in patients with 
degenerative cerebellar ataxia in the Netherlands are inconsistent and 
suboptimal. Referral rates are high, but there is a discrepancy between referrals 
and actual indication for treatment. Patients with functional problems often 
do not use physiotherapy. More than half of the patients who had never been 
referred reported that physiotherapy had not been discussed by their physician. 
It is possible that physicians are not sufficiently aware of the possible benefit of 
physiotherapy or there may be a lack of time to screen for relevant indications 
in the clinic. Another interesting finding was that the proportion of patients who 
did not want to be referred was relatively larger in the group of patients who 
experienced more disabilities, up to 57 percent. This might be due to mobility 
problems, a fear to go outside, or cognitive problems, which could all hold 
patients back from travelling. Training at home, whether or not supervised by a 
physiotherapist, could be a solution for this specific group. Despite the specific 
functional impairments patients had reported on several domains, they had often 
not selected these items as a goal for treatment. Additionally, physiotherapists 
chose more training goals than their patients, but always included the goals 
selected by the patient. Consequently, better pre-treatment discussions between 
patient and therapist may lead to more specific training program and might 
increase patient satisfaction. 
 The consequences of the relatively low prevalence of patients with 
degenerative cerebellar ataxia are the relatively low caseload per physiotherapist, 
and the absence of specific training programs on top of the lack of evidence-
based recommendations. So, as expected, physiotherapists reported a lack of 
ataxia-specific expertise, and they used measurement instruments that have not 
been designed for patients with ataxia to evaluate the training effect. Therefore, 
concentration of care is essential to optimize treatment of patients with ataxia. 
The ataxia field could adopt the approach of ParkinsonNet, a Dutch professional 
network of allied health care workers who have received specific training in 
Parkinson’s disease, and who attract a high caseload of these patients.17 
 Treatment duration was long and training methods were not in accordance 
with the limited scientific evidence that was actually available. The majority of 
physiotherapists believed that chronic treatment on a weekly basis is needed for 
their patients. This is in contrast to what the literature is suggesting, namely that it 
might be more effective to start an intensive, high frequency training program first,  
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followed by less intensive and low-frequency training at home or at the physio-
therapist’s practice. In order to make such training programs feasible, it could be 
useful to refer a patient to a specialized physiotherapist or rehabilitation center 
first, followed by a tailored treatment plan taken over by general physiotherapists. 
Again, more research is warranted to develop the best training protocols and 
eventually evidence-based guidelines and the implementation thereof.
 We then went on to test a very specific component of a putative training 
program for patients with ataxia. Adjustment of gait patterns to variable 
requirements of the environment is essential to avoid falls, and we wanted to 
examine whether gait adaptability training might be useful for patients with 
cerebellar ataxia.
In chapter 4.3, the results of a pilot study that evaluated the effect of gait 
adaptability training on obstacle avoidance and dynamic stability in patients 
with degenerative cerebellar ataxia are described. Ten patients received 10 
protocolised gait adaptability training sessions of 1 hour each for 5 weeks. 
Training was performed on a treadmill with visual stepping targets and obstacles 
projected on the belt’s surface. As the primary outcome measure, an obstacle 
avoidance task while walking on a treadmill was used. An embedded force 
platform, video recordings, and 3D-markers were used to assess avoidance 
success rates and dynamic stability during the obstacle avoidance tasks. 
Patients also performed clinical tests including the Scale for the Assessment of 
Ataxia (SARA), the 10 meter walking test, the Timed Up-and-Go Test, the Berg 
Balance Scale, and the obstacle subtask of the Emory Functional Ambulation 
Profile (EFAP). After the training, success rates on the obstacle avoidance 
task had improved by 16 percent compared to pre-intervention. For successful 
avoidance, participants allowed themselves smaller stability margins in the 
sagittal plane, while using a shortened pre-crossing step more often. However, 
in the subsequent steps they returned to baseline stability values more quickly 
than before training. SARA scores and the EFAP obstacle subtask also improved 
significantly. Participants reported to experience more confidence in daily life 
situations and reported fewer falls, albeit not statistically significant, probably 
due to the small sample size in this pilot study.
This pilot study showed a beneficial effect of gait adaptability training on obstacle 
avoidance capacity and dynamic stability in patients with cerebellar degeneration, 
which suggests a potential for improving safe daily life ambulation. In a study 
evaluating a similar training program in healthy elderly, not only a positive 
effect on obstacle avoidance capacity was found, but also on the frequency of 
falls.23 A long-step strategy was strongly preferred by the healthy elderly and 
this preference did not change over time, while patients with cerebellar ataxia 
in this study more frequently used a short-step strategy after training. These 
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results cautiously suggest that this type of gait adaptability training could be 
part of training programs for ataxia patients. Yet, future studies should include 
more patients and control interventions, have longer follow-up times to evaluate 
the sustainability of improvements, and assess whether the results translate 
to actual benefit in daily life (such as a reduction of falls). The gait adaptability 
training used in this pilot study was well appreciated by participants, in particular 
the gaming element at the end of each training session, which combined the 
different exercises patients had practised. The problem is that this type of 
training, in this specific set-up, is not possible at home. A more feasible option 
could be whole-body training based on recently developed and commercially 
available videogame technology, under supervision by a physiotherapist.24, 25 
Additionally, by using these videogames, a more feasible training program for 
patients who are not able to walk or travel without assistance could be designed. 
 An interesting neurobiological issue is the question why such types of 
training lead to improvement. We suspect that training, alongside other effects, 
triggers cerebral changes and more specifically boosts cerebral compensatory 
mechanisms. To investigate this, we are now doing a follow-up study in which 
patients undergo functional MRI scanning before and after this training protocol. 
We hope to extract the cerebral compensatory mechanisms in patients with 
a cerebellar defect. A next step could then be to try and stimulate these 
compensatory areas with neuromodulation techniques such as transcranial 
magnetic stimulation (TMS) or transcranial direct current stimulation (tDCS),  
and to test whether such interventions, as an add-on to training, have synergistic 
effects.26, 27
 In conclusion, cerebellar ataxia has major consequences for daily life, 
of which falls are a clear example. It makes sense to refer patients for 
physiotherapy or other forms of training, but the actual scientific evidence 
to support this is limited. Patients are being referred, but there is mismatch 
between necessity and usage, treatment programs are very heterogeneous,  
and therapists lack specific expertise. Good quality trials are needed, also as  
an important first step to develop evidence-based guidelines for allied healthcare 
interventions. When such guidelines become available, therapists can be trained, 
and in this regard, we can learn from the model used by ParkinsonNet, aiming 
at delivering the best possible multidisciplinary treatment.17, 28, 29 This way of 
organizing care will make it easier for both patients and physicians to select the 
most appropriate therapist to refer to, and might improve quality of care,  
possibly even at lower societal costs.
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Cerebellaire ataxie is een neurologische bewegingsstoornis, die met name 
gekenmerkt wordt door coördinatieproblemen. Deze uiten zich als balans- 
en loopproblemen, vallen, slik- en spraakstoornissen en verminderde 
handvaardigheid. Ataxie kan door verscheidene ziekten worden veroorzaakt. 
Hoofdstuk 1 geeft een overzicht van deze ziekten met een praktische leidraad 
hoe men in de dagelijkse praktijk tot een diagnose en behandelplan kan 
komen. Belangrijk hierbij zijn een gedegen anamnese en een aantal specifieke 
bevindingen bij het lichamelijk onderzoek. Indien een MRI-scan van de hersenen 
structurele pathologie heeft uitgesloten, zijn inflammatoire en heredodegeneratieve 
stoornissen de twee meest voorkomende etiologische groepen.
 De in dit proefschrift beschreven studies richtten zich op de 
heredodegeneratieve ataxieën. Deze aandoeningen zijn progressief en leiden 
tot een verminderde mobiliteit, vallen en een afname van de kwaliteit van leven. 
Ten gevolge van het ontbreken van medicamenteuze behandelopties speelt 
de paramedische hulpverlening een belangrijke rol in de behandeling van deze 
ziekten. Er was echter weinig bekend over in welke mate en op welke wijze 
fysiotherapie werd toegepast bij deze groep van patiënten. Tevens was er weinig 
wetenschappelijk bewijs voor deze behandeling voorhanden, met als gevolg 
hiervan ook een gebrek aan richtlijnen voor deze patiëntengroep.
Hoofdstuk 2 De belangrijkste doelen van dit proefschrift waren: 
•  het in kaart brengen van de incidentie, details en gevolgen van vallen in 
patiënten met autosomaal-dominante cerebellaire ataxieën,
•  het verzamelen en beoordelen van wetenschappelijke studies betreffende 
paramedische interventies voor cerebellaire ataxie,
•  het verkrijgen van meer inzicht in het gebruik van fysiotherapie, de tevredenheid 
van patiënten, de mate van expertise en de behoeften van fysiotherapeuten die 
deze patiënten behandelen.
Tevens werden de effecten van een specifieke looptraining bij patiënten met een 
degeneratieve ataxie onderzocht.
 
Hoofdstuk 3.1 en hoofdstuk 3.2 beschrijven de resultaten van de EuroSCA-
valstudie. 228 Patiënten met SCA1, SCA2, SCA3 of SCA6 vulden een vragenlijst 
in over vallen in de voorafgaande twaalf maanden. 113 patiënten hielden een 
valdagboek bij tussen hun jaarlijkse bezoeken aan hun behandelend neuroloog 
en vulden hiernaast ook vragenlijsten in over de eerste drie vallen. 73,6 procent 
van de patiënten in de retrospectieve groep en 81,4 procent van de patiënten 
in de prospectieve groep rapporteerden ten minste één val in deze periode. De 
resultaten toonden aan dat vallen verschillende gevolgen had voor de patiënten, 
waaronder letsels en het vermijden van activiteiten ten gevolge van angst om 
te vallen. Factoren die geassocieerd waren met een hogere valfrequentie in de 
retrospectieve studie waren ziekteduur, ernst van de ataxie, de aanwezigheid van 
pyramidale verschijnselen, het totale aantal symptomen anders dan ataxie en 
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het genotype SCA3. Factoren geassocieerd met een lagere valfrequentie waren 
de aanwezigheid van extrapiramidale verschijnselen (en dan vooral dystonie van 
de onderste ledematen) en het genotype SCA2. Het totaal aantal niet-ataxie 
symptomen en langere ziekteduur waren onafhankelijk geassocieerd met een 
hogere valfrequentie in een logistische regressieanalyse, terwijl de aanwezigheid 
van extrapiramidale verschijnselen onafhankelijk geassocieerd was met een 
lagere valfrequentie. Ook bleek dat valllen ook in de vroege stadia van de ziekte 
voorkomt. De prospectieve studie bevestigde dat de aanwezigheid van niet-ataxie 
symptomen geassocieerd is met een hogere valfrequentie.
 Deze resultaten dragen bij aan de ‘awareness’ bij hulpverleners (en 
patiënten) over het hoge valrisico bij deze patiënten en helpen ook om die 
ataxiepatiënten met een grotere kans op vallen te identificeren. 
Hoofdstuk 4.1 bevat een literatuurstudie naar klinisch onderzoek met 
betrekking tot paramedische interventies bij cerebellaire ataxie. 14 studies 
werden geselecteerd, waarvan de vier beste studies formeel als van matige 
methodologische kwaliteit beoordeeld werden. Er was een grote variatie 
in ziektebeelden, aantal onderzochte patiënten, soorten interventies en 
uitkomstmaten. De meeste studies hadden geen controle-interventie gebruikt. 
 De studies suggereren dat fysiotherapie kan leiden tot een vermindering 
van de ataxie en een verbetering kan geven van ADL- functies bij patiënten met 
een degeneratieve cerebellaire ataxie, en andere ziekten die gepaard gaan met 
cerebellaire ataxie. Wanneer uitgevoerd in combinatie met fysiotherapie, kan 
ergotherapie het algemene functioneren verbeteren en ergotherapie alleen zou 
symptomen van een depressie kunnen verminderen. Er waren onvoldoende 
studies over logopedie. Er werd dus enig bewijs voor de toepassing van 
fysiotherapie en ergotherapie bij ataxie gevonden, maar meer studies van betere 
kwaliteit zijn nodig om aanbevelingen te doen en richtlijnen voor de klinische 
praktijk te ontwikkelen.
Hoofdstuk 4.2 beschrijft de resultaten van een onderzoek naar fysiotherapie 
bij degeneratieve cerebellaire ataxieën in Nederland. Hierbij werd gekeken naar 
de mate van gebruik van fysiotherapie, de tevredenheid van patiënten hierover 
en de professionele expertise van de fysiotherapeuten. Er werden vragenlijsten 
aan patiënten met een autosomaal-dominante cerebellaire ataxie gestuurd 
en vervolgens werd ook een vragenlijst aan hun fysiotherapeuten verzonden. 
Uiteindelijk konden 317 vragenlijsten van patiënten en 114 vragenlijsten 
van fysiotherapeuten gebruikt worden voor verdere analyse. 64 procent van 
de patiënten werden op dat moment behandeld door een fysiotherapeut. 
Hun gemiddelde behandelingsduur was 5 jaar. 19 procent van de patiënten 
was nog nooit verwezen, vaak ondanks de aanwezigheid van beperkingen in 
hun dagelijkse activiteiten. Anderzijds werden sommige deelnemers zonder 
beperkingen al wel door een fysiotherapeut behandeld. Bijna één op de tien 
patiënten bezocht een fysiotherapeut zonder verwijzing van een arts. Het aantal 
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patiënten die geen fysiotherapeut wensten te bezoeken nam toe met de ernst 
van de problemen in de voorgaande maand. De genoemde redenen waren 
onder andere ‘geen verwachte voordelen',' zelf oefeningen doen' en 'gebrek 
aan tijd'. De meest gerapporteerde behandelingsdoelen waren verbetering 
of onderhoud van de balans, de algemene fysieke conditie en mobiliteit. Het 
aantal patiënten dat verbetering bemerkte varieerde van 10,7 procent van 
de patiënten met (zeer) ernstige problemen tot 75 procent van de patiënten 
zonder problemen in functioneren in de voorgaande maand. Eén derde van de 
therapeuten rapporteerde verbeteringen bij hun patiënten. In het algemeen waren 
de deelnemers tevreden over hun fysiotherapeut. Patiënten die geen verbetering 
van de problemen ondervonden waren minder tevreden. Fysiotherapeuten 
behandelden gemiddeld 2 patiënten met ataxie in het voorgaande jaar. Ze 
vermeldden een tekort aan ataxie-specifieke expertise en gaven aan behoefte te 
hebben aan onderwijs en evidence-based richtlijnen. 
 Dit onderzoek toont dus dat de behandeling van fysiotherapie bij ataxie 
gerichter moet worden ingezet en dat er op studies gebaseerde richtlijnen moeten 
komen met daaraan gekoppelde scholing voor therapeuten.
In hoofdstuk 4.3 worden de resultaten van een pilotstudie beschreven, die het 
effect van een looptraining bij patiënten met degeneratieve cerebellaire ataxie 
beschreven. De looptraining richtte zich op het loopspecifieke aanpassings-
vermogen om obstakels te ontwijken en op de dynamische stabiliteit. Tien 
patiënten kregen 10 geprotocolleerde trainingen van telkens 1 uur gedurende 
5 weken. De training werd uitgevoerd op een loopband waarbij visuele stappen, 
doelen en obstakels geprojecteerd werden op het oppervlak van de loopband. 
Als primaire uitkomstmaat werd een ‘obstakel vermijdings-taak’ tijdens het lopen 
op een loopband gebruikt. Een ingebouwd krachtplatform, video-opnames en 
3D-markers werden gebruikt voor de beoordeling van de succespercentages van 
het vermijden van het obstakel en de dynamische stabiliteit tijdens deze taak. 
Er werden ook klinische scores afgenomen zoals de Scale for the Assessment 
of Ataxia (SARA-score), de 10 meter looptest, de Timed Up-and-Go Test, de Berg 
Balance Schaal en het obstakelonderdeel van de Emory Functional Ambulation 
Profile (EFAP). Na de training waren de succespercentages op het vermijden van 
de obstakels met 16 procent toegenomen ten opzichte van voor de training. Om 
succesvol de obstakels te kunnen vermijden, lieten deelnemers een verminderde 
stabiliteit toe in het voorachterwaartse vlak, terwijl een verkorte stap voor het 
obstakel vaker werd toegepast. In de daaropvolgende stappen keerden de 
stabiliteitswaarden sneller terug naar de beginwaarden dan voor de training. 
De SARA-scores en de prestatie op het EFAP obstakelonderdeel verbeterden 
aanzienlijk. Hoewel niet statistisch significant (waarschijnlijk vanwege de kleine 
groep), gaven deelnemers aan meer vertrouwen tijdens situaties in het dagelijkse 
leven te ervaren en rapporteerden ze minder te vallen.
114 CHAPTER 5 SUMMARY AND DISCUSSION 
Concluderend is 1) vallen een veelvoorkomend probleem bij patiënten met 
ataxie, met soms ook ernstige gevolgen, 2) een specifieke looptraining nuttig 
bij patiënten met ataxie, mogelijk ook voor het vallen, maar is meer onderzoek 
nodig o.a. naar het beste trainingsprotocol en 3) er een behoefte aan een 
behandelrichtlijn en scholing voor fysiotherapeuten specifiek voor ataxie. 
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